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The prevalence of nonmedical prescription drug (NMPD) use continues to increase among 
emerging adult populations; however, little is known about the motivations behind this use.  The 
current study aimed to extend previous research by developing and validating the first known 
comprehensive NMPD motives measure.  As such, the primary focus of the current study was to 
examine evidence for the reliability and validity of the NMPD Motives Questionnaire by 
assessing the factor structure, internal consistency, and construct validity of the motives scale.  
Participants were drawn from a larger study of college student substance use behaviors and 
attitudes (N = 1,427; Mage= 19.8; 65% female; 48.5% White Non-Hispanic) from two public 
universities in the United States. From the larger sample, 423 individuals (Mage= 19.9; 62% 
female; 53% White Non-Hispanic) reported lifetime NMPD use and thus were included in the 
final study sample.  Participants completed online self-report questionnaires, including the 
NMPD Motives Questionnaire.  Following data reduction procedures, the final measure included 
20-items in which respondents indicated reasons they use NMPDs on a scale of 1 (Almost 
Never/Never) to 5 (Almost Always/Always).  Exploratory factor analyses revealed a four-factor 
model of NMPD motives; including: social/recreation, performance, conformity, and self-
medication.  Results of the current study suggest the overall scale and each of the four subscales 
of the NMPD Motives Questionnaire demonstrate good to excellent internal consistency, 
providing evidence for reliability.  Moreover, results also suggest strong convergent, 
discriminant, and concurrent validity of the developed NMPD motives measure.  Similar to 
patterns observed for other types of substance use, social/recreation, performance, and self-
medication motives for NMPD use were found to be significant positive predictors of the 





findings suggest self-medication NMPD motives significantly predict NMPD-related problems 
after controlling for use.  These findings support incremental validity of the developed measure.  
Taken together, results of this study support the NMPD Motives Questionnaire as a potentially 
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Development and Preliminary Validation of a Nonmedical Prescription Drug Motives 
Questionnaire 
Emerging Adulthood 
Emerging adulthood has been identified as a critical developmental period in which an 
individual transitions from adolescence to adulthood (Arnett, 2000; 2005).  While generally 
defined as spanning the ages of 18 to 25, Arnett (2005) reported that this period may continue 
through the twenties (i.e., ages 18-29).  Emerging adulthood is characterized by an increase in 
autonomy combined with a notable shift in social context, social roles, and normative 
expectations for their behavior.  In addition, national studies have consistently identified 
emerging adulthood as the age period in which prevalence is highest for most types of drug use.  
According to the 2013 National Survey on Drug Use and Health (NSDUH), those aged 18-25 
reported the highest rates of alcohol use (70%), current binge alcohol use (43%), tobacco use 
(37%), marijuana use (19%), and other illicit drug use (21%) compared to any other age group.   
Previous research has highlighted the role of five distinct features of emerging adulthood 
that may be associated with the apparent increased vulnerability to substance use during this 
developmental period (Sussman & Arnett, 2014).  Specifically, Arnett (2000, 2004, 2005) 
characterized emerging adulthood as the age of (a) identity exploration, (b) instability, (c) 
possibilities, (d) self-focus, and (e) feeling in-between.  Identity exploration refers to a feature in 
which the emerging adult explores who they are and who they want to be.  As part of this 
exploration, the individual may be more likely to pursue a variety of new and intense experiences 
(e.g., sensation seeking) and engage in risky behaviors (e.g., substance use) before they reach 
adulthood.  Alternatively, identity exploration may generate internal distress and confusion about 





instability in social context and other disruptions that are often present during this developmental 
period may promote substance use to cope or self-medicate in an attempt to reduce negative 
affect. The third feature, characteristic of emerging adulthood is the “age of possibilities.”  
Arnett (2005) describes this feature as being extremely optimistic with unlimited hopes and 
dreams for the future.  In terms of substance use, this overly optimistic outlook may contribute to 
the emerging adult ignoring any potential negative consequences of their behaviors, such as car 
accidents, being arrested, or developing a substance use disorder. Being self-focused appears to 
be associated with less concern about damaging relationships within the social network (i.e., 
social control) and therefore may increase the likelihood of engaging in risky, non-normative 
behaviors. Finally, the “age of in-between” refers to the individual not feeling like an adolescent 
or an adult and consequently may believe that their substance use behaviors are normal and that 
they will grow out of them when they become an adult. Taken together, emerging adulthood is a 
key period for the initiation of problematic substance use behaviors and thus an important target 
population for prevention efforts.   
Nonmedical Prescription Drug Use 
Over the past two decades, prevalence rates of nonmedical prescription drug (NMPD) use 
(i.e., using a prescription drug without a legitimate prescription or taking a prescription drug in 
ways not prescribed by a physician) have rapidly increased in the United States (U.S.) and 
constitute an important public health concern.  According to the 2013 NSDUH, an estimated 7 
million (2.5 percent) persons, aged 12 or older, reported NMPD use in the past month.  Similar 
to age-related trends seen with other substances, individuals aged 18-25 report the highest rates 
of NMPD use, abuse, and dependence based on the DSM-IV criteria (Substance Abuse and 





among this age group, college students may be at a particularly high risk for NMPD use 
compared to their non-college peers (Herman-Stahl, Krebs, Kroutil, & Heller, 2007; McCabe, 
Teter, & Boyd, 2006).  The literature generally recognizes four distinct classes of nonmedical 
prescription drugs (see McCabe, Boyd, & Teter, 2009):  (a) Pain relievers (e.g., opioids such as 
Vicodin®, OxyContin®, Percocet®, Tylenol with codeine, oxycodone); (b) Stimulants (e.g., 
Ritalin®, Adderall®); (c) Sleeping/Sedative medications (e.g., Ambien®, Seconal®); and (d) 
Tranquilizers (e.g., Xanax®, Valium®).  Between 1993 and 2005, rates of all four of types of 
these prescription drugs increased substantially (ranging from 93% - 450%) among college 
students (National Center on Addiction and Substance Abuse [NCASA], 2007).  Moreover, 
previous studies indicate that with the exception of marijuana, college students report higher 
rates of NMPD use than all other forms of illicit drug use (e.g., cocaine, heroin, inhalants; 
McCabe & Teter, 2007; NCASA, 2007).  
In addition to being highly prevalent, NMPD use has been linked to a number of 
problems and risky behaviors within young adult and college student samples.  Specifically, 
individuals who endorse NMPD use indicate higher rates of unintentional injuries, motor vehicle 
crashes, physical fights, academic problems, and unplanned and unprotected sex (Benotsch, 
Koester, Luckman, Martin, & Cejka, 2011; Herman-Stahl et al., 2007; Martins, Storr, Zhu, & 
Chilcoat, 2009).  Benotsch and colleagues (2011) found that young adults (ages 18-25) who 
endorse NMPD use were more likely to have multiple sex partners, to have sex after drinking or 
using other drugs, and to have engaged in unprotected sex when compared to their non-using 
counterparts.  Moreover, evidence suggests that a sizeable proportion of individuals that report 
NMPD use meet criteria for DSM-IV NMPD abuse or dependence (Kroutil et al., 2006; Zacny et 





who report NMPD use will develop abuse, while 6-13% will develop dependence during their 
lifetime. 
Taken together, the epidemiological trend of increasing NMPD use among college 
students combined with the association between NMPD use and adverse outcomes, suggest the 
need to better understand the psychological factors influencing the use of these drugs.  Though 
limited research has explored potential motives, or reasons, for using NMPDs (McCabe, 
Cranford, Boyd, & Teter, 2007; McCabe, Teter, & Boyd, 2005; Rigg & Ibanez 2010; Teter, 
McCabe, Cranford, Boyd, & Guthrie, 2005), there is no known standardized instrument designed 
and validated to measure motivations for NMPD use.  Therefore, the purpose of the present 
research is to develop and test the psychometric properties of an instrument, called the 
“Nonmedical Prescription Drug Motives Questionnaire.”  
Motives versus Expectancies 
 While several explanatory factors have been implicated when examining problematic 
substance use among emerging adults, evaluative cognitions about substances such as 
expectancies and motives are perhaps the most predictive (Carey & Correia, 1997; Christiansen 
& Goldman, 1983; Read, Wood, Kahler, Maddock & Palfai, 2003). The majority of the research 
to date has examined substance use expectancies and motives in relation to alcohol use 
behaviors.  Alcohol expectancies are conceptualized as a distal factor that begins well before an 
individual initiates alcohol use and refer to beliefs about the positive and negative effects of 
consuming alcohol (Brown, Goldman, Inn, & Anderson, 1980; Christiansen, Goldman, & Inn, 
1982; Goldman, Del Boca, & Darkes, 1999).  Previous research has consistently supported the 
association between positive alcohol expectancies (e.g., I would be friendly) and reported 





Reis & Riley, 2000; Zamboanga, Leitkowski, Rodriguez, & Cascio, 2006; Zamboanga, 
Schwartz, Ham, Borsari, & VanTyne, 2010).  Findings related to negative alcohol expectancies 
(e.g., I would feel guilty) and reported use are less clear; however, across studies positive alcohol 
expectancies have been a stronger predictor of problematic use than negative alcohol 
expectancies (Leigh & Stacy, 1993, Valdivia & Stewart, 2005).  For a more thorough review of 
alcohol expectancies among emerging adults, see Ham and Hope (2003).   
 Motives are conceptualized as a proximal factor of substance use behavior and refer to 
the values or psychological function placed on the desired effect of the substance use, which in 
turn serves as motivation for use (Cox & Klinger, 1988).  In other words, the substance use can 
produce an outcome that is of value to the person and thus motivates them to engage in substance 
use behaviors.  While conceptually distinct, alcohol expectancies and drinking motives are 
considered to be highly correlated concepts.  Previous research suggests that alcohol 
expectancies are developed prior to drinking motives (Cooper, Frone, Russell, & Mudar, 1995) 
and as such an individual who has a positive alcohol expectancy related to social function may 
be more likely to report social motives for use (Cooper, 1994).   Research has consistently 
demonstrated that drinking motives are powerful predictors of problematic alcohol use among 
emerging adults (Carey & Correia, 1997; Ratliff & Burkhart, 1984).   
Motivational Models of Substance Use 
Motivation is a multifaceted construct that captures the internal and external drives that 
influence a person’s behavior (Mitchell, 1982).  As mentioned above, research and theory 
suggests that motivation is a critical mechanism in understanding substance use behaviors 
(Cooper, 1994; Cox & Klinger, 1988; Simons, Correia, Carey, & Borsari, 1998).  Specifically, 





behaviors which holds important implications for prevention and intervention efforts (Cooper, 
1994).   
Models of motivation for substance use have been conceptualized as demonstrating two 
underlying dimensions, namely valence (positive or negative reinforcement) and source (internal 
or external source; see Cooper, 1994; Cox & Klinger, 1988).  Briefly defined, positive 
reinforcement occurs when a person receives a pleasurable sensation or experiences an appetitive 
state following a behavior that in turn drives them to repeat the behavior.  Negative 
reinforcement, on the other hand, occurs when the person avoids a negative outcome or aversive 
state following a behavior that in turn drives them to repeat the behavior.  Taken together, 
research indicates that a person’s substance use behaviors are typically motivated by the desire to 
obtain a specific outcome (e.g., enhance positive mood or regulate negative affect).    
Drinking Motives. To date, the majority of literature examining motivational models of 
substance use has focused on (or been adapted from) models of drinking motives (e.g., Carey & 
Correia, 1997; Cooper, 1994; Cox & Klinger, 1988; Gire, 2002; Lee, Neighbors, Hendershot, & 
Grossbard, 2009; Simons et al., 1998; Stewart, Zeitlin, & Samoluk, 1996).  Cooper (1994) 
developed the most commonly used measures of drinking motives, the Drinking Motives 
Questionnaire (DMQ-R), which assesses four distinct, theoretically driven classes of motives for 
alcohol use: (1) enhancement (e.g., “Because you like the feeling”),  (2) social (e.g., “Because it 
makes social gatherings more fun”), (3) coping (e.g., “To forget your worries”), and (4) 
conformity (e.g., “To fit in with a group you like”).  Enhancement and social motives are 
associated with positive reinforcement, by increasing either positive affect (internal source) or 
enjoyment in a social function (external source).  Coping and conformity, on the other hand, are 





avoiding social criticism (external source).  Drinking motives are strong predictors of heavy 
alcohol use and alcohol-related problems (Carey & Correia, 1997; Cooper et al., 1995; Simons et 
al., 1998).  Research suggests that coping motives and enhancement motives are most strongly 
associated with negative consequences and problems.  Enhancement motives typically exhibit 
indirect associations with alcohol use and problems (Cooper et al., 1995; Read et al., 2003), 
while coping motives exhibit both direct and indirect associations with alcohol use and problems 
(Cooper et al., 1995; Simons et al., 1998).   
 Marijuana use motives. Repeated empirical support for a motivational model of alcohol 
use prompted researchers to examine the utility of a motivational model in regards to other 
substances.  Simons, Correia, Carey, and Borsari (1998) adapted and extended Cooper’s (1994) 
DMQ-R to examine the motives involved in marijuana use.  The fifth motives scale in the MMM 
was created by 1) using three items from Newcomb, Chou, Bentler and Huba’s (1988) motives 
scale, which is a measure designed to assess the generality of motives across both alcohol and 
marijuana, and 2) reviewing relevant literature (cf. Simons, Correia, & Carey, 2000).  Results 
supported a five-factor Marijuana Motives Measure (MMM).  Similar to drinking motives, 
enhancement, social, coping, and conformity were found as distinct factors influencing use.  
Additionally, the MMM introduced a unique motive in marijuana use: expansion (e.g., “To 
expand your awareness”).   
Within the motivational model, expansion motives are considered to be another facet of 
positive reinforcement by “expanding experiential awareness” (internal source).  In a comparison 
of alcohol and marijuana motives, Simons et al. (2000) found differing functional roles of 
alcohol and marijuana use among users.  In other words, Cooper’s (1994) DMQ-R and Simons et 





different substances.  Furthermore, coping and conformity motives were shown to generalize 
across drugs.  This provides support for the existence of distinct motives for each type of 
substance use, in addition to possible universal motive factors for substance use generally.   
 Smoking Motives. Within the literature, smoking motives have also been widely studied 
in order to better understand smoking-related behaviors, problems, and use.  Ikard, Green, and 
Horn (1969) suggest a six-factor model of smoking motives, including stimulation (e.g., “I 
smoke cigarettes to stimulate me, to perk myself up”), pleasurable relaxation (e.g., “Smoking 
cigarettes is pleasant and relaxing”), sensorimotor manipulation (e.g., “Handling a cigarette is 
part of the enjoyment of smoking it”), habit (e.g., “I smoke cigarettes automatically without even 
being aware of it”), negative affect reduction (e.g., “When I feel uncomfortable or upset about 
something, I light up a cigarette”), and addictive (e.g., “I get a real gnawing hunger for a 
cigarette when I haven’t smoked for a while”).  While previous research has generally suggested 
that drinking and smoking motives are positively associated with one another (Novak, Burgess, 
Clark, Zvolensky, & Brown, 2003), there are several important conceptual and theoretical 
differences in motivations for use when comparing these substances.  Specifically, research 
examining other substance use behaviors, such as alcohol and marijuana, have not revealed 
habitual or sensory motivations for use.  These factors appear to be unique to smoking behaviors.  
In addition, tobacco use is a legal behavior in the U.S. for adults 18 and older with consequences 
of use centering on health effects.  While alcohol use is also considered a legal behavior for U.S. 
adults aged 21 years and older, consequences of use may include health effects as well as a 
myriad of other problems, including unintentional injuries, missing classes/work, engaging in 
unplanned and/or unprotected sexual activity, forgetting what they did, property damage, and 





motivations for smoking appear to be conceptually different from motivations for alcohol use 
and other illicit substances. 
NMPD Use Motives Research 
 The shared theories and significant empirical overlap associated with both marijuana and 
alcohol use motives suggest that an expansion of the motivational models of substance use could 
be appropriate for application to measurement of NMPD use motives.  For example, tension 
reduction and social influence are commonly associated with substance use in general (Arnett, 
2005, Simons et al., 1998), which align with motives for alcohol and marijuana use.  Research 
indicates that a considerable portion of young adults report “self-treatment” and 
recreation/enhancement motives for NMPD use (Babcock & Byrne, 2000; Barrett, Darredeau, 
Bordy, & Pihl, 2005; Boyd, McCabe, Cranford, & Young, 2006; McCabe et al., 2007; McCabe 
et al., 2009; Teter et al., 2005).  Boyd and McCabe (2008, p. 2) define self-treatment as being 
“motivated by the desire to alleviate symptoms consistent with prescription drug’s 
pharmaceutical main indication and does not involve the co-ingestion with alcohol or other drugs 
or non-therapeutic routes of administration.”  While some common motivational factors are 
expected to underlie alcohol, marijuana, and NMPD use, previous models do not account for 
motives unique to NMPD use and may omit key predictors of use.  Specifically, across 
prescription drug classes individuals consistently report self-medication motives (McCabe et al., 
2009; Rozenbroek & Rothstein, 2011).  Self-medication is expected to be different from 
previously mentioned coping or self-treatment motives in that it is expected to be associated with 
negative reinforcement but reflect a mix of internal and external sources of reinforcement.  Self-
medication as a unique motive for NMPD use is expected to better capture the complexity of 





stimulant users may report motives related to internal sources of reinforcement (e.g., alleviate 
problems with attention and concentration; Aikins, 2011; Judson & Langdon, 2009; Teter et al., 
2005; Upadhyaya et al., 2010) and external sources of reinforcement (e.g., perform better on 
school work, or in other words, to avoid bad school performance; DeSantis, Webb & Noar, 2008; 
Low & Gendaszek, 2002; Weyandt, et al., 2009).  Both motives indicate the desire to avoid a 
negative outcome through self-medication.  Other examples of self-medication motives for 
NMPD use include weight loss/appetite suppression (DeSantis et al., 2008; Judson & Langdon, 
2009; Low & Gendaszek, 2002; Rabiner et al., 2008), pain management (Lord, Brevard & 
Budman, 2011; McCabe et al., 2007), counteracting the effects of other drugs (Judson & 
Langdon, 2009; Teter et al., 2005), and coping with negative affect (Aikins, 2011; Lord et al., 
2011; Rabiner et al., 2009).   
To date, the majority of studies examining college student motives for NMPD use have 
focused on two specific prescription drug class; namely, stimulants or opioids. Little research has 
focused on sedative or tranquilizer use motives, on NMPD use motives as a group, or on 
polydrug use related to NMPDs.   
Stimulants. The majority of empirical articles that examine NMPD use motives among 
college students focus specifically on stimulant misuse (Aikins, 2011; Barrett et al., 2005; 
DeSantis et al., 2008; DuPont, Coleman, Bucher, & Wilford, 2008; Judson & Langdon, 2009; 
Low & Gendaszek, 2002; Rabiner et al., 2008, 2009; Teter et al., 2005; Teter, McCabe, 
LaGrange, Cranford, & Boyd, 2006; Upadhyaya et al., 2010; Weyandt et al., 2009). 
Drawing on findings from both quantitative surveys (n = 585) and qualitative interviews 
(n = 175), DeSantis and colleagues (2008) examined motives for the repeated nonmedical use of 





nonmedical stimulant use; namely, academic motives and nonacademic motives.  Academic 
motives were defined as stimulant use for the “more serious pursuit of getting good grades.”  
Within this academic motivation category, results revealed three common reasons for 
nonmedical stimulant use.  Specifically, 72% of the total nonmedical user sample reported using 
stimulants to stay awake and study, 66% reported using to concentrate on work, and 36% 
reported using to help memorize information.  Importantly, the authors highlight that based on 
the interviews conducted, these motives are largely driven by a desire to study for longer periods 
of time or to reduce distractibility and increase productivity.  While it is clear based upon the 
higher percentage of individuals indicating academic motives that doing better is school is a 
central motive for stimulant use, the authors also examined nonacademic motives.  Defined as 
motives for use deriving from recreational or social purposes, nonacademic motives included: 
staying awake to have fun (22%), making work more interesting (12%), to get high (7%), to 
suppress appetite (5%), and self-medication (4%).  Interviewer comments suggested that the 
common thread among nonacademic motives were either to increase energy levels (e.g., reduce 
fatigue) or to be more outgoing at social events.  
Perhaps not surprisingly, academic motives (e.g., to study, increase concentration, 
increase alertness, perform better on tests or schoolwork) were among the most commonly 
reported motives for nonmedical prescription stimulant use among college student samples using 
quantitative (Aikins, 2011; Barrett et al., 2005; DeSantis et al., 2008) and qualitative methods 
(DuPont et al., 2008; Judson & Langdon, 2009; Low & Gendaszek, 2002; Rabiner et al., 2008, 
2009; Teter et al., 2005, 2006; Upadhyaya et al., 2010; Weyandt et al., 2009).   
Across multiple studies, students appeared to report similar types of nonacademic 





2008; Teter et al., 2005, 2006), party (DuPont et al, 2008; Low & Gendaszek, 2002), counteract 
the effects of another substance (Teter et al., 2005; Low & Gendaszek, 2002; Rabiner et al., 
2008), experimentation (Judson & Langdon, 2009; Teter et al., 2006), lose weight (Judson & 
Langdon, 2009; Rabiner et al., 2008), exercise (Judson & Langdon, 2009; Low & Gendaszek, 
2002), self-medication (Rabiner, 2009; Upadhyaya et al., 2010), and calming effects (Aikins, 
2011).  Overall, nonacademic motives were consistently reported less frequently than academic 
motives, with the exception of one study.  Barrett and colleagues (2005) found academic motives 
(e.g., to help study) were only reported by 30% of the students engaging in nonmedical 
prescription stimulant use, whereas 70% of this population reported “recreational use” to be their 
primary motives for stimulant use.  Moreover, among the students who identified as being 
recreational users, a striking 77.1% also reported using other psychoactive substances (e.g., 
alcohol) simultaneously. 
Garnier-Dykstra, Caldeira, Vincent, O’Grady, and Arria (2012) present the only 
longitudinal study to examine motivations for any type of NMPD use among college students; 
however, it should be noted that the study is somewhat limited in scope given its exclusive focus 
on nonmedical prescription stimulant use.  Participants (n = 1,253) were assessed at four time 
points (i.e., Years 1, 2, 3, and 4 of college) and completed both self-report surveys and a face-to-
face interview.  Results of these qualitative data suggest that motives for nonmedical prescription 
stimulant use change over time as the student advances in college.  Specifically, students in their 
early years of college were more likely to indicate curiosity or experimentation as motivation for 
use.  Alternatively, students who were in their later years of college were more likely to report 
academic motives (e.g., studying).  Drawing upon these findings, the authors posit that over the 





from novelty seeking purposes to the pursuit of an “academic shortcut.” However, an 
examination of the connection of these motives to actual NMPD use outcomes as well as a 
quantitative analysis of NMPD use motives is lacking in the literature.  
Taken together, the existing literature suggests that motivations for nonmedical 
prescription stimulant use among college students typically fall within two broad categories: 
academic motives and nonacademic motives (see DeSantis et al., 2008).  Academic motives were 
by far the most common reason for use reported by college students engaging in the nonmedical 
use of prescription stimulants.   
Opioids. Only two articles have examined motivations for the nonmedical use of 
prescription opioids among college students.  McCabe and colleagues (2007) found college 
students most frequently reported one of three motivations for nonmedical prescription opioid 
use; namely: to relieve pain, to get high, and experimentation.  Generally consistent with the 
aforementioned study, Lord and colleagues (2011) found relaxation, to get high, to have fun, and 
experimentation as being the most commonly reported motives for nonmedical prescription 
opioid use among college students.  Although somewhat less prevalent, other motives for 
nonmedical prescription opioid use included: self-medication (e.g., to cope with depression, to 
manage pain), weight management, and academic enhancement.  One study has found support 
that motives for nonmedical opioid use were associated with nonmedical opioid use. 
Specifically, individuals who reported regular opioid use were also more likely to report motives 
for to be to relax, to get high, or to have fun compared to students who reported less frequent or 
no use in the past year (McCabe et al., 2007).   Taken together, college students appear to be 





medicating (including pain management and to cope with depression or tension), and there is 
some evidence that these motives are associated with use.   
“All” drug types. Only two known publications have focused on motives for “all” drug 
types separately among a college student sample.  Rozenbroek and Rothstein (2011) found that 
regardless of drug type (e.g., stimulants, depressants, or opioids); academic enhancement was the 
most commonly reported reason for engaging in the use of a prescription drug for nonmedical 
purposes.  Specifically, approximately 54% of stimulant users, 22% of depressant users, and 4% 
of opioid users identified academic motives as their principles reasons for use. Holloway and 
Bennett (2012) examined motives for NMPD use among a non-U.S. (Wales) college student 
population.  Findings suggest that motivations for NMPD use differed according to the specific 
drug type.  In accordance with the expected effect of the drug, motivations for use of nonmedical 
prescription depressants (e.g., sleeping aids, sedatives, and anti-depressants) were most 
commonly cited as “to sleep” or to manage symptoms of anxiety or depression.  Similar to 
findings presented in U.S. populations (Lord et al., 2011; McCabe et al., 2007), the most 
common motive reported (93%) by college students for nonmedical prescription opioid use was 
to relieve pain (e.g., self-medicate).  Interestingly, findings related to nonmedical stimulant use 
in this population were markedly different from studies examining stimulant use among U.S. 
college students.  Specifically, the majority of students reporting nonmedical stimulant use 
indicated nonacademic motives (e.g., “for pleasure” or “to play sport”), while only 3% of the 
sample indicated academic motives (e.g., “to study” and “to stay awake). 
 Taken together, a review of the existing literature revealed the most common motives 
reported by college students include academic enhancement, self-medication, “to get high,” and 





(e.g., use of different drugs on separate occasions; Newcomb & Bentler, 1988) suggest that 
individuals may consume different prescription drug types (e.g., depressants, stimulants, opioids, 
mixed-use) based on the desired effect for a particular situation.   
Current study 
Motives for substance use are widely regarded as the final common pathway to use and 
abuse (Cooper, 1994; Cox & Klinger, 1988).  Moreover, research indicates that by understanding 
the motives or “reasons for using” a substance, we gain insight into possible risk level for a given 
individual as well as the ideal strategies for behavior change.  An abundance of literature suggest 
motives for alcohol and marijuana use are often strong predictors of substance-related problems 
and consequences (e.g., Cooper, 1994; Simons et al., 1998) Therefore, the development of a 
comprehensive, psychometrically sound measure of NMPD motives may be important for 
understanding reasons for NMPD use and their relation to use behaviors.  A better understanding 
of NMPD motives may be an important aspect for guiding the assessment of drug use as well as 
the development of effective interventions. 
  The current study aimed to extend previous research on motives for NMPD use by 
developing and validating a comprehensive NMPD motives measure.  A secondary aim in the 
development of a psychometrically sound measure of NMPD motives was to provide a common 
language for researchers who seek to examine specific motive dimensions related to the use of 
NMPDs.  The current study examined evidence for the reliability and validity of the NMPD 
Motives Questionnaire by assessing the factor structure, internal consistency, and construct 
validity of the motives scale.   
In order to accomplish these study aims, several steps were followed.  First, a principle 





Questionnaire.  It was expected that NMPD motives would have a similar overarching factor 
structure to those found for drinking and marijuana use motives.  As such, five distinct motives 
scales were expected to emerge from the content items, namely, self-medication, 
recreation/enhancement, social, conformity, and expansion. Next, reliability was determined by 
examining internal consistency of the overall model as well as each of the emerging factors. 
Convergent validity (e.g., the measure is positively correlated with measures of related 
constructs) and discriminant validity (e.g., the measure is not highly correlated with measures of 
non-related constructs) was examined by testing associations between NMPD motives and other 
substance use motives, positive affect, negative affect, sensation seeking, and demographic 
variables.  It was hypothesized that motives driven by positive reinforcement (i.e., 
recreation/enhancement, social, expansion) would be highly correlated with positive affect and 
sensation seeking.  Moreover, positive reinforcement motives were expected to be uncorrelated 
with negative affect.  It was also hypothesized that motives driven by negative reinforcement 
(i.e., self-medication and conformity) would be highly correlated with negative affect and mostly 
uncorrelated with positive affect and sensation-seeking.  Concurrent validity, or the extent to 
which the measure is associated with theoretically associated outcomes measured at the same 
time, was examined by testing the association between NMPD motives and NMPD use behaviors 
(i.e., frequency of use and use-related problems).  To more fully test concurrent validity, the 
ability of motives to predict NMPD use and problems above and beyond relevant covariates was 







Development of the NMPD Motives Questionnaire. Initial items for the NMPD motives 
questionnaire were generated based upon 1) a review of identified motives for NMPD use in the 
literature (Aikins, 2011; Barrett et al., 2005; DeSantis et al., 2008; DuPont et al., 2008; Holloway 
& Bennett, 2012; Judson & Langdon, 2009; Lord et al., 2011; Low & Gendaszek, 2002; McCabe 
et al., 2007; Rabiner et al., 2008, 2009; Rozenbroek & Rothstein, 2011; Teter et al., 2005, 2006; 
Upadhyaya et al., 2010; Weyandt et al., 2009) and 2) a review of items on two  existing 
theoretically-based motives measures [DMQ-R (Cooper, 1994) and MMM (Simons et al, 1998)] 
and one data-driven motives measure [MMQ (Lee et al., 2008)].  The author initially generated a 
list of 82 items by drawing from previous motives measures of other substances and the current 
literature examining motives for NMPD use.  The items were then categorized into five different 
motive categories based upon theory of substance use motivations (Cooper, 1994; Cox & 
Klinger, 1988) and a review of relevant literature.  The five expected motive categories include: 
self-medication, recreation/enhancement, social, conformity, and expansion.  The self-
medication category included items that were thought to reflect motivation driven by negative 
reinforcement or the avoidance of negative outcomes that arise from internal sources.  Self-
medication was expected to include motives related to six subcategories including, coping with 
negative affect (e.g., “to forget about your problems”), pain management (e.g., “because it 
relieves your pain”), counteracting the effects of other drugs (e.g., “to avoid withdrawal from 
alcohol or other drugs”), coping with sleep difficulties (e.g., “to help you sleep”), improving 
attention/alertness (e.g., to reduce inattention), and weight/appetite management (e.g., “to lose 
weight”). The recreation/enhancement category includes items that are thought to reflect 
motivation driven by positive reinforcement through internal sources, specifically to increase 





category includes items that are thought to reflect motivation driven by positive reinforcement 
from external sources, specifically increase positive social outcomes (e.g., “because it helps you 
enjoy a party”).  The conformity category includes items that are thought to reflect motivation 
driven by negative reinforcement from external sources, specifically to avoid peer rejection (e.g., 
“so you won’t feel left out”).  Finally, the expansion category includes items that are thought to 
reflect motivation driven by positive reinforcement, specifically expanding internal experiences 
of perceptual and cognitive awareness (e.g., “to understand things differently”).  The author then 
examined each of the five motive categories and selected items that appeared to be a good 
representation of the individual motive based on the definition of the category.  Redundant items 
(n = 15) and items that did not fit into the categories (n = 12; e.g., “because it’s readily 
available”) were eliminated. The final item pool included in preliminary analyses consisted of 55 
NMPD motive items that were expected to load onto five distinct factors: self-medication (29 
items); recreation/enhancement (8 items); social (5 items); conformity (6 items); and expansion 
(7 items).  The 55-item measure was administered in the current study and ultimately reduced to 
20 items for primary analyses, as described in the data analytic strategy and Results sections. 
Participants 
Participants were drawn from a larger study of college student substance use behaviors 
and attitudes (N = 1,427; Mage= 19.8; 65% female; 48.5% White Non-Hispanic) from two public 
universities in the United States. From the larger sample, 423 individuals reported lifetime 
NMPD use (i.e., Have you ever used a prescription drug that was not prescribed to you, or used it 
in ways for which it was not prescribed?) and reported ages between 18 and 29 and thus were 
included in the final study sample.  Participants were predominately women (62%) with a mean 





followed by White Hispanic (28.4%), African-American/Black (6.6%), Asian/American 
Indian/Pacific Islander (4.7%), Hispanic/Latino (4.5%), and those who endorsed “other” (1.9%).  
Four participants (0.9%) did not report their race/ethnicity.  See Table 1 for a complete summary 
of demographic information for the final study sample and the larger sample from which 
participants were drawn. 
Within the final study sample, 73.7% of participants reported lifetime nonmedical 
stimulant use and 64.4% reported lifetime nonmedical opioid use.  Lifetime nonmedical sedative 
use and tranquilizer use was less frequent within the current sample, with 32.5% and 35.6% 
respectively.  These findings are consistent with other studies examining NMPD use among 
emerging adult samples (McCabe, Cranford, Teter, Rabiner, & Boyd, 2012).  See Table 2 for a 
complete summary of lifetime frequency of NMPD use by drug type category.   
Measures 
Demographics. Participants provided basic demographic information, including gender, 
age, ethnicity/race, employment, marital status, and year in school (see Table 1).  
NMPD Motives Questionnaire. Nonmedical prescription drug motives for use was 
assessed with the NMPD Motives Questionnaire developed specifically for this validation study, 
as described above.  The NMPD Motives Questionnaire is a 55-item self-report measure in 
which respondents indicate possible reasons they use NMPDs.  This measure was found to center 
around four factors (see below): social/recreation (e.g., “because it’s fun”); performance (e.g., 
“to perform better on school work or on tests”); conformity (e.g., “so others won’t kid you about 
not doing it”); and self-medication (e.g., “to forget about my problems”). Items are assessed on a 
5-point scale: 1 = Almost never/never, 2 = Some of the time, 3 = Half of the time, 4 = Most of the 





Substance Use Questionnaire.  Alcohol, tobacco, and illicit drug use was assessed by 
self-report.  Individuals reported frequency of use in the past 6-months across 10 domains of licit 
and illicit substances using a 5-point scale: 1 = Never, 2 = Less than monthly, 3 = Monthly, 4 = 
Weekly, 5 = Daily/Almost daily.  Lifetime use was also assessed using a dichotomous yes/no 
scale for each of the 10 drug types by asking “Have you EVER used this substance in your 
lifetime?” 
NMPD Use.  NMPD use was assessed by self-report.  Individuals reported frequency of 
NMPD use in the past 6-months across the 4 drug types on a 5-point scale: 1 = Never, 2 = Less 
than monthly, 3 = Monthly, 4 = Weekly, 5 = Daily/Almost Daily.  Participants also reported 
frequency of lifetime NMPD use across the 4 drug types on a 7-point scale: 1 = Never, 2 = 1-3 
times, 3 = 4-6 times, 4 = 7-10 times, 5 = 11-20 times, 6 = 21-40 times, 7 = 41 or more times.   
NMPD Problems measure.  A modified version of the Short Inventory of Problems 
(SIP-PDM; modified from Blanchard, Morgenstern, Morgan, Labouvie, & Bux, 2003) was used 
to assess problems related to NMPD use.  This measure was adapted for NMPDs by substituting 
“prescription drug misuse” for “drinking.”  Items include statements such as, “I have been 
unhappy because of my prescription drug misuse” and “My prescription drug misuse has 
damaged my social life, popularity, or reputation.”  The SIP-PDM is a 15-item measure that 
measures physical, social, intrapersonal, impulsive, and interpersonal consequences of NMPD 
use.  Respondents indicate whether or not each item has occurred (Yes/No) as a result of NMPD 
use. Each “yes” response is coded as “1” and each “no” is coded as “0” and summed.  The SIP 
has demonstrated excellent internal consistency, regardless of substance category used 
(Cronbach’s alphas range from .93-.96; Blanchard et al., 2003).  Internal consistency in the 





Drug Use Motives.  The positive scale of the Drug Use Disorders Identification Test – 
Extended (DUDIT-E; Berman, Palmstierna, Kallmen, & Bergman, 2007) is a 17-item self-report 
measure assessing positive reasons for substance use (“What is positive for you about using 
drugs?”) across areas of emotional well-being (e.g., “I can control feelings like anxiety, anger, 
and depression”), individual competence (e.g., “Become creative”), physical well-being (e.g., 
“Sleep better”), and social competence (e.g., “With drugs I can function socially”).  Items are 
assessed on a 5-point scale assessing reasons identified for substance use, ranging from 1 (Not at 
all) to 5 (Totally).  Berman and colleagues (2007) reported excellent internal consistencies of the 
positive scale of the DUDIT-E (Cronbach’s alpha = .92-.95). Analysis of internal consistency in 
the present sample revealed excellent internal consistency (α = .94).  
Drinking Motives.  The Drinking Motives Questionnaire (DMQ-R; Cooper, 1994) is a 
20-item self-report questionnaire assessing four motives for drinking: enhancement (e.g., “I drink 
to get high”), social (e.g., “I drink to be sociable”), coping (e.g., “I drink to forget my worries”), 
and conformity (e.g., “I drink so that others won’t kid me about not drinking”).  Items are 
assessed on a 5-point scale assessing frequency of drinking for each motive, ranging from 1 
(Almost never/never) to 5 (Almost always/always).  Each scale consists of five items that are 
aggregated into average scale scores. This measure has demonstrated sound psychometric 
properties in large samples of adolescents and adults (Cooper, 1994; Cooper et al., 1995), and 
across various demographics within college student samples (Ham, Bonin, & Hope, 2007; Ham, 
Zamboanga, Bacon, & Garcia, 2009; Lecci, MacLean, & Croteau, 2002; Martens, Cox, Beck, & 
Heppner, 2003; Neighbors, Larimer, Geisner, & Knee, 2004; Stewart, Loughlin, Rhyno, 2001). 
Internal consistency was found to be good in the present sample (enhancement motives: α = .87, 





Affect.  The Positive and Negative Affect Schedule (PANAS; Watson, Clark, & 
Tellegen, 1988) was used to assess two global dimensions of affect: (1) negative and (2) positive.  
The PANAS is a well-established mood measure which consists of 20-items measured across a 
5-point Likert scale (1 = Very slightly or not at all to 5 = Extremely) examining the extent to 
which they experience different emotions and feelings at the present moment.  Both positive and 
negative affect subscales have demonstrated good convergent and discriminant validity, as well 
as high levels of internal consistency (Tuccitto, Giacobbi, & Leite, 2010).  Construct validity has 
been supported through use of confirmatory factor analysis techniques in previous studies.  In a 
2004 study conducted by Crawford and Henry, the best-fitting model (robust comparative fit 
index = .94) of the latent structure of the PANAS consisted of two correlated factors 
corresponding to the positive affect and negative affect scales.  Crawford and Henry (2004) 
reported the internal consistency of the PANAS, as measured by Cronbach’s alpha, as .89 for 
positive affect and.85 for negative affect.  Analysis of internal consistency in the present sample 
revealed good to excellent internal consistency (positive affect: α = .91, negative affect: α = .89). 
Sensation Seeking. The Arnett Inventory of Sensation Seeking (AISS; Arnett, 1994) is a 
20-item self-report questionnaire assessing two domains of sensation seeking: intensity and 
novelty.  The intensity scale measures the intensity of stimulation of the senses (e.g., “If I were 
to go to an amusement park, I would prefer to ride the rollercoaster or other fast rides”).  The 
novelty scale measures openness to experience (e.g., “I can see how it would be interesting to 
marry someone from a foreign country”).  Items are assessed on a 4-point scale, ranging from 1 
(describes me very well) to 4 (does not describe me at all).  Arnett (1994) reported the internal 
consistency of the AISS, as measured by Cronbach’s alpha, as .70 for the total scale, .50 for 





consistency was questionable for the overall scale (α = .60), poor for novelty sensation seeking 
(α = .50) and unacceptable for intensity sensation seeking (α = .48).  Similarly low coefficients 
have been reported by several other studies (see Andrew & Cronin, 1997; Roth & Herzberg, 
2004; Zarevski, Marusic, Zolotic, Bunjevac, & Vukosav, 1998). Researchers have postulated that 
the low internal consistencies of the AISS may be due to problems within the scale development 
(e.g., selecting items based on content validity rather than psychometric analysis; Roth & 
Herzberg, 2004).  To address low subscale reliability coefficients, a modified AISS scale was 
utilized in which items with the lowest item scale correlations were removed until the alpha 
coefficient was maximized.  A similar modification procedure has been utilized by several 
previous researchers due to reliability problems with the AISS (e.g., Haynes, Miles, & Clements, 
2000; Ravert et al., 2013; Roth, 2003).  Following item reduction, a principal components 
analysis (varimax rotation) was used to verify that the two dimensional structure of the measure 
was retained.  The procedure resulted in two components (eigenvalues 2.57 and 1.49) that 
accounted for 37.0% of the total variance (see Table 5), and included a 6-item novelty scale (α = 
.60) and a 5-item intensity scale (α = .52). The modified 11-item scale also yielded a slightly 
higher internal consistency for the overall scale (α = .64) within the current sample.   
Procedure 
The current study was conducted via an online survey at two public universities 
administered through Qualtrics®.  Of note, Qualtrics® provides a high level of security and 
meets standards for both the Health Insurance Portability and Accountability Act (HIPPA) and 
the Family Educational Rights and Privacy ACT (FERPA).  Students were recruited from 
psychology courses through the Subject Pool recruitment system and provided a link to an online 





study, costs and benefits of participation, and contact information for the researcher.  
Importantly, identifiable participant information was kept separate from responses to study items 
and deleted immediately after the end of the semester in which participation occurred.  The 
names of participants were never connected to their responses and no other identifiable 
information was collected that could connect a participant’s identity to their responses. 
After participants voluntarily provided consent, indicating that they read and understood 
the purpose of the study and agreed to participate, they were redirected to a separate survey site 
to complete the study questionnaires.  All measures were presented in counterbalanced order. 
Upon completion of the study, participants were presented with an electronic debriefing form 
which included information about the study aims, as well as contact information for the 
researchers, university Institutional Review Board, and mental health resources.  All procedures 
were approved by the Institutional Review Board. 
Data Analytic Plan 
Prior to central analyses, data were examined for missingness, normality, and the 
presence of outliers.  Specifically, frequencies and descriptive analyses were examined to 
determine data errors and appropriate coding of variables.  In addition, the data were analyzed 
for normality to determine the appropriateness of use of various statistical procedures.   
The primary data analytic approach consisted of four stages.  First, an exploratory 
principal component analysis (PCA) was conducted to examine the factor structure of the NMPD 
Motives Questionnaire and identify psychometrically sound and distinct motives for NMPDs.  
Given the novelty of the NMPD Motives Questionnaire and that no study has empirically 
identified NMPD use motives factor structure, a confirmatory factor analysis would have been 





Second, data reduction procedures were used to further reduce the list of items based 
upon findings in the exploratory PCA of the initial 55-items.  Any items that loaded on more 
than one factor were first removed, leaving 43-items. The item list was further reduced to include 
five items per subscale, using factor loadings and nonredundancy of item content as primary 
criteria. The final NMPD Motives Questionnaire included 20 items across four factors (see Table 
4).  A second PCA was conducted and verified that the four-dimensional structure of the measure 
was retained in the reduced version. As such, the 20-item NMPD Motives Questionnaire was 
used for all subsequent analyses. 
Third, internal consistency of the overall scale and each of the emerging factors were 
assessed using Cronbach’s alpha.  Finally, convergent, discriminant, and concurrent validity of 
the NMPD Motives Questionnaire was evaluated using Pearson correlations. Convergent validity 
(e.g., the measure is positively correlated with measures of related constructs) and discriminant 
(e.g., the measure is not highly correlated with measure of non-related constructs) was examined 
by testing the association between NMPD motives and other substance use motives (DMQ-R and 
DUDIT-E), positive affect, negative affect, sensation seeking, and demographic variables. Of 
note, the DUDIT-E positive scale demonstrated high intercorrelations (r > .70) among its four 
subscales (i.e., emotional well-being, individual competence, physical well-being, and social 
competence).  Moreover, previous studies have indicated problematic factor loadings among the 
subscales, including cross-loadings and items not loading on thematically expected components 
(e.g., “physical pain” loaded on the social competence subscale rather than the physical well-
being subscale; Berman, 2009).  Given the problems related to the aforementioned subscales, 





 Pearson correlations were used to test the hypothesis that motives driven by positive 
reinforcement (i.e., social/recreation and performance) would be highly correlated with positive 
affect, sensation seeking, drug use motives, social drinking motives, and enhancement drinking 
motives. Moreover, positive reinforcement motives were expected to be mostly uncorrelated 
with negative affect, conformity drinking motives, and coping drinking motives.  It was also 
hypothesized that motives driven by negative reinforcement (i.e., self-medication and 
conformity) would be highly correlated with negative affect, drug use motives, conformity 
drinking motives, and coping drinking motives.  Further, negative reinforcement motives were 
expected to be mostly uncorrelated with positive affect, sensation-seeking, social drinking 
motives, and enhancement drinking motives.  
Concurrent validity, or the extent to which the measure is associated with theoretically 
associated outcomes measured at the same time, was examined by testing the association 
between NMPD motives and NMPD use behaviors (i.e., frequency of overall NMPD use and use 
problems). To more fully test concurrent validity, the ability of motives to predict NMPD use 
and problems above and beyond relevant covariates was tested using hierarchical linear 
regressions. This provided an index of the measure’s incremental validity.  
Results 
Preliminary Analyses 
Data cleaning. Of the larger sample (N = 1,427), 438 individuals reported lifetime 
NMPD use and were considered for inclusion in the current study.  Of the 438 NMPD users, nine 
participants were outside of the study age range, five participants did not complete the study (i.e., 
did not reach the study’s debriefing page), and one participant was identified as a random 





removed from the sample.  The final data set consisted of 423 participants.  See Table 1 for 
demographic frequencies.   
Of note, an experimenter error was made in the questionnaire administered to students at 
the University of North Texas data collection site.  Specifically, the Short Inventory of Problems 
– PDM, used to assess NMPD-related problems, repeated item #4 (i.e., “I have felt guilty or 
ashamed because of my prescription drug misuse.”) and consequently omitted item #5 (i.e., “I 
have taken foolish risks when I have misused prescription drugs.”).  As such, all analyses that 
included this measure were limited to data collected at the University of Arkansas (n = 241). 
Checking statistical assumptions.  All measures were initially analyzed with respect to 
means, standard deviations, skewness, and kurtosis.  There were no univariate or multivariate 
outliers. Negative affect, conformity drinking motives, and conformity NMPD motives were 
positively skewed (skewness statistic >2; Tabachnick & Fidell, 2007).  All other variables were 
normally distributed with no significant skew or kurtosis. A logarithmic transformation on the 
negative affect and drinking conformity motives resulted in statistical normality for both 
variables.  Though analyses using the transformed variables are presented, analyses conducted 
with untransformed variables resulted in the same pattern of results. No transformations were 
conducted on conformity NMPD motives as this is a validation study of the NMPD Motives 
Questionnaire.  Scatterplots and correlations suggest linearity and an absence of multicollinearity 
(Pearson correlations < .7; Tabachnick & Fiddell, 2007).  See Table 6 for correlation matrix.   
Primary Analyses 
Exploratory factor analysis.  In order to identify psychometrically sound and distinct 
motives for NMPDs, the 55-items of the NMPD Motives Questionnaire were subjected to an 





suitability of data for factor analysis was assessed. Inspection of the correlation matrix revealed 
the presence of many coefficients of .3 and above.  The Kaiser-Meyer-Olkin value was .96, 
exceeding the recommended value of .6 (Kaiser, 1970, 1974) and Bartlett’s Test of Sphericity 
(Bartlett, 1954) reached statistical significance (p < .001), supporting the factorability of the 
correlation matrix.   
A PCA revealed the presence of four components (eigenvalues > 1), explaining 54.4%, 
7.8%, 6.5%, and 3.9% of the variance respectively (see Table 3).  Results of parallel analysis 
(Horn, 1965) further supported retention of 4 factors, which all had salient loadings of >.40.  
Item communalities generally ranged from .65 to .80, and all communalities were greater than 
.60. Based on item content, the scales were labeled Social/Recreation, Performance, Conformity, 
and Self-Medication.  Data reduction procedures were used to reduce the list of items, first by 
dropping any item that loaded on more than one factor.  Based on these criteria, 43 items were 
retained.  The item list was further reduced to five per subscale, using factor loadings and 
nonredundancy of item content as primary criteria. For example, the items with the top two 
factor loadings were retained for the second factor (performance motives). The third item “to 
help you study” was not retained as it was judged to be redundant with the second item “to 
perform better on school work or on tests.” The fourth item “to help you concentrate” was also 
not retained as it was judged to be redundant with the first item “to help focus.”  Therefore, the 
item with the fifth highest factor loading, “because it helps to increase your alertness” was 
retained as the fourth item on this scale. The sixth item “to stay awake” was not retained as it 
was judged to be redundant with the fifth item “because it helps to increase your alertness.”  The 
seventh item “to help you stay organized” was then retained as the fifth item on this scale. The 





The 20-items of the reduced NMPD Motives Questionnaire were examined using a PCA 
to verify that the four-dimensional structure of the measure was retained.  Preliminary analyses 
were assessed to determine suitability of data for factor analysis.  The Kaiser-Meyer-Olkin value 
of the reduced scale was .91, exceeding the recommended value of .6 (Kaiser, 1970, 1974) and 
Bartlett’s Test of Sphericity (Bartlett, 1954) reached statistical significance (p < .001), again 
supporting the factorability of the correlation matrix. Consistent with initial findings, the PCA of 
the 20-item measure resulted in four components (eigenvalues > 1) that accounted for 75.4% of 
the total variance (see Table 4).  All subsequent analyses will be conducted using the 20-item 
NMPD Motives Questionnaire. 
Internal Consistency. Internal consistency was assessed using Cronbach’s alpha for the 
overall 20-item NMPD Motives Questionnaire and each of the four factors.  Overall, the NMPD 
Motives Questionnaire total score demonstrated excellent internal consistency (α = .91).  Each of 
the four motive subscales also demonstrated good to excellent internal consistencies: 
Social/Recreation (α = .93), Performance (α = .93), Conformity (α = .90), and Self-Medication (α 
= .89). 
Convergent and discriminant validity.  Pearson correlations were conducted to 
evaluate convergent and discriminant validity of the NMPD Motives Questionnaire subscales 
(see Table 6). Specifically, NMPD social/recreation motives demonstrated a large positive 
correlation with the DUDIT-E positive scale (p < .001) and a medium positive correlation with 
enhancement drinking motives (p < .001). NMPD social/recreation motives demonstrated small 
positive correlations with social drinking motives (p < .001), coping drinking motives (p < .001), 





sensation seeking (p < .01), and negative affect (p < .001). Interestingly, NMPD social/recreation 
motives were not correlated with positive affect (p = .07). 
NMPD performance motives demonstrated medium positive correlations with social 
drinking motives (p < .001) and the DUDIT-E positive scale (p < .001). NMPD performance 
motives demonstrated small positive correlations with coping drinking motives (p < .001), 
enhancement drinking motives (p < .001), and conformity drinking motives (p < .001), as well 
as, positive affect (p < .01), and negative affect (p < .01). NMPD performance motives were not 
correlated with novelty sensation seeking (p = .10) and intensity sensation seeking (p = .06). 
NMPD conformity motives demonstrated medium positive correlations with conformity 
drinking motives (p < .001), negative affect (p < .001), and the DUDIT-E positive scale (p < 
.001). NMPD conformity motives demonstrated small positive correlations with social drinking 
motives (p < .05), coping drinking motives (p < .001), and enhancement drinking motives (p < 
.01); as well as, positive affect (p < .05). NMPD conformity motives were not correlated with 
novelty sensation seeking (p = .76) and intensity sensation seeking (p = .45).  
Finally, NMPD self-medication motives demonstrated a large positive correlation with 
the DUDIT-E positive scale (p < .001), and medium positive correlations with coping drinking 
motives (p < .001) and negative affect (p < .001). In addition, NMPD self-medication motives 
demonstrated small positive correlations with social drinking motives (p < .01), enhancement 
drinking motives (p < .001), and conformity drinking motives (p < .001).  NMPD self-
medication motives were not correlated with positive affect (p = .37), novelty sensation seeking 
(p = .13), and intensity sensation seeking (p = .24). 
NMPD Type and NMPD Motives. Pearson correlations were also conducted to examine 





social/recreation motives demonstrated a strong positive correlation with lifetime opioid use (p < 
.001) and moderate positive correlations with lifetime nonmedical stimulant use (p < .001) and 
nonmedical tranquilizer use (p < .001).  In addition, social/recreation motives demonstrated 
small positive correlations with lifetime nonmedical sedative use (p < .001).   
NMPD performance motives demonstrated a strong positive correlation with lifetime 
nonmedical stimulant use (p < .001).  In addition, NMPD demonstrated small positive 
correlations with lifetime nonmedical sedative use (p < .05) and nonmedical tranquilizer use (p < 
.001).  Of note, performance motives for NMPD use were not associated with lifetime 
nonmedical opioid use (p = .53).  
NMPD conformity motives demonstrated small positive correlations with lifetime 
nonmedical opioid use (p < .001), nonmedical stimulant use (p < .01), nonmedical sedative use 
(p < .001), and nonmedical tranquilizer use (p < .001).  
Lastly, NMPD self-medication motives demonstrated moderate positive correlations with 
lifetime nonmedical opioid use (p < .001), nonmedical sedative use (p < .001), and nonmedical 
tranquilizer use (p < .001).  In addition, self-medication motives demonstrated small positive 
correlations with lifetime nonmedical stimulant use (p < .001).   
Demographics and NMPD Motives. For the following analyses, gender was entered as 
a dichotomous variable (man = 0, woman = 1) to facilitate interpretation.  Analysis of Variance 
(ANOVA) results indicate social/recreation motives for NMPD use was significantly higher 
among men (M = 2.31, SD = 1.23) compared to women (M = 1.97, SD = 1.21), F(1,418) = 7.82, 
p < .01.  NMPD social/recreation motives, conformity motives, and self-medication motives 
were all significantly positively associated with age. No racial/ethnicity differences were found 





Concurrent and Incremental Validity. NMPD social/recreation motives demonstrated 
a strong positive correlation with lifetime NMPD use (p < .001) and moderate positive 
correlations with NMPD problems (p < .001).  In addition, social/recreation motives for NMPD 
use demonstrated small to moderate correlations with recent licit and illicit substance use (see 
Table 8 for details).  Interestingly, social/recreation motives for NMPD use were not associated 
with lifetime alcohol use, t (392) = -1.64, p = .10; however, social/recreation motives for NMPD 
use were significantly correlated with frequency of alcohol use in the past 6-month alcohol use 
frequency (p < .01). 
NMPD performance motives demonstrated a moderate positive correlation with NMPD 
use (p < .001).  In addition, performance motives for NMPD use demonstrated small positive 
correlations with NMPD problems (p < .01), past 6-month alcohol use (p < .001), and recent licit 
and illicit substance use (see Table 8 for details). Of note, performance motives for NMPD use 
were not associated with lifetime alcohol use, t (386) = -1.37, p = .17. 
NMPD conformity motives demonstrated small positive correlations with NMPD use (p 
< .001), NMPD problems (p < .01), and recent licit and illicit substance use (see Table 8 for 
details). Of note, conformity motives for NMPD use were not associated with lifetime, t (393) = 
1.58, p = .12 or past 6-month alcohol use (p = .42). 
Lastly, NMPD self-medication motives demonstrated moderate positive correlations with 
NMPD problems (p < .001) and NMPD use (p < .001).  In addition, self-medication motives for 
NMPD use demonstrated small positive correlations other licit and illicit substance use (see 
Table 8 for details).  Self-medication motives for NMPD use were not associated with lifetime 
alcohol use, t (387) = -0.01, p = .99; however, were significantly correlated with past 6-month 





Hierarchical regression analyses (see Table 9) were used to assess the ability of the 
NMPD motives to predict NMPD use, after controlling for the influence of age, gender, race, and 
frequency of other substance use.  Age, gender, race, and frequency of other substance use were 
entered at Step 1, explaining 35% of the variance in NMPD use.  After entry of the four NMPD 
motive subscales at Step 2, the total variance explained by the model as a whole was 46.5%, 
F(13,386) = 25.86, p < .001. The four NMPD motives explained an additional 11.7% of the 
variance in NMPD use, after controlling for age, gender, race, and frequency of other substance 
use, R
2
∆ = .117, F∆(4, 386) = 21.10, p < .001. In the final model, three covariates remained 
significant: age (b = .150, t = 3.91, p <.001), cigarette use (b = .121, t = 2.68, p <.01), and 
cocaine use (b = .280, t = 5.13, p <.001). The strongest predictor of NMPD use was 
social/recreation motives (b = .268, t = 4.71, p <.001), followed by performance motives, (b = 
.178, t = 4.42, p <.001), and self-medication motives (b = .107, t = 1.98, p <.05).  Conformity 
motives did not make a unique statistically significant contribution to the final model b = -.024, t 
= -.52, p = .61).   
Next, a second hierarchical regression analysis (see Table 10) was conducted to examine 
NMPD-related problems as a function of motives after accounting for NMPD use and other 
covariates (e.g., age, gender, and race).  Age, gender, race, and NMPD use were entered at Step 
1, explaining 27.2% of the variance in NMPD-related problems.  After entry of the four NMPD 
motive subscales at Step 2, the total variance explained by the model as a whole was 34%, 
F(8,225) = 14.47, p < .001. The four NMPD motives explained an additional 6.8% of the 
variance in NMPD use, after controlling for age, gender, race, and NMPD use, R
2
∆ = .068, F∆(4, 
225) = 5.77, p < .001. In the final model, NMPD use remained the strongest predictor of NMPD-





medication motives predicted NMPD-related problems (b = .256, t = 3.32, p <.001).  No other 
NMPD motive made a unique statistically significant contribution to the final model; namely: 
social/recreation motives (b = .065, t = .81, p = .42), performance motives (b = .000, t = -.01, p = 
.99), and conformity motives (b = -.004, t = -.07, p = .95). 
Discussion 
Nonmedical prescription drug use is one of the fastest growing drug problems in the 
United States, with emerging adults reporting the highest prevalence rates (SAMHSA, 2014).  
While the current literature examining NMPD use has provided some important insight into the 
epidemic, a better understanding of the psychological factors (e.g., motives) influencing the 
decision to initiate and continue engaging in NMPD use is critical for prevention and 
intervention efforts.  Previous research examining NMPD motives has been largely qualitative in 
nature and thus limited in terms of the psychometric properties needed for quantitative research. 
As such, the present study aimed to extend previous research on motives for NMPD use by 
developing and validating the “Nonmedical Prescription Drug Motives Questionnaire.” 
The current study describes the development and preliminary evidence for the reliability 
and validity of a comprehensive NMPD motives measure. The 55-items of the initial iteration of 
the measure revealed a four-factor model of NMPD motives; including: social/recreation (e.g., to 
enhance social outcomes or positive affect), performance (e.g., to produce favorable performance 
outcomes or enhance productivity), conformity (e.g., to avoid rejection or encourage acceptance 
by peers), and self-medication (e.g., to mitigate negative affect or physical problems).  Using 
factor loadings and nonredundancy of item content, the measure was reduced to include 5-items 





DMQ-R).  Importantly, the reduced 20-item scale maintained the overall four-factor solution.  As 
such, the 20-item NMPD Motives Questionnaire was used for all primary analyses. 
Internal consistency for the overall scale and each of the four subscales ranged from good 
to excellent and demonstrated strong convergent, discriminant, and concurrent validity.  The 
overall pattern of findings was generally consistent with the study’s theoretically driven 
hypotheses for each NMPD motive. Supporting convergent validity, social/recreation and 
performance motives (i.e., motives driven by positive reinforcement) were more strongly related 
to drug use motives (assessed by the DUDIT-E positive scale), enhancement drinking motives, 
and social drinking motives.  In addition, both social/recreation and performance motives 
demonstrated only small associations with conformity drinking motives, coping drinking 
motives, and negative affect. Alternatively, conformity and self-medication motives (i.e., 
motives driven by negative reinforcement) were more strongly related to conformity drinking 
motives, coping drinking motives, negative affect, and drug use motives (assessed by the 
DUDIT-E positive scale).  In addition, conformity and self-medication motives demonstrated 
only small associations with social drinking motives and enhancement drinking motives, and 
were not related to sensation seeking. 
Interestingly, social/recreation NMPD motives demonstrated a stronger association with 
enhancement drinking motives and small positive associations with social drinking motives, 
novelty sensation seeking, and intensity sensation seeking. Moreover, social/recreation motives 
were not related to positive affect.  This finding is inconsistent with previous research (e.g., 
Cooper, 1994) as well as the thematic nature of the subscale (e.g., to increase positive affect or to 
enhance social experiences).  Performance motives, on the other hand, demonstrated a stronger 





drinking motives, and positive affect. As expected, performance motives were not associated 
with novelty or intensity sensation seeking. Notably, within the current study positive affect was 
associated with enhancement drinking motives but not associated with social drinking motives.  
It is unclear why positive affect is not associated with social motives for substance use within the 
current sample; however, this finding may point to the complexity of NMPD use given the 
current sample is restricted to individuals reporting lifetime NMPD use.   
An examination of the relation between NMPD type and NMPD motives provided 
additional support of convergent and discriminate validity.  Social/recreation motives 
demonstrated a strong relation with lifetime opioid, stimulant, and tranquilizer use, as well as a 
small relation with lifetime sedative use.  As expected, performance motives demonstrated a 
strong association with lifetime stimulant use and small associations with lifetime sedative and 
tranquilizer use.  Moreover, performance motives were not associated with lifetime opioid use.  
One possible explanation for this finding is that students may be engaging in NMPD use to 
improve performance on a task by 1) increasing their focus/alertness (i.e., stimulant use) and/or 
2) reducing general distress for the purpose of being more productive (i.e., sedative use and 
tranquilizer use).  This finding is generally consistent with results reported by Rozenbroek and 
Rothstein (2011) in which 54% of stimulant users and 22% of depressant users reported 
academic motives (e.g., performance-related motives) as their primary reason for use, while only 
4% of opioid users reported academic motives.  A small association was found between 
conformity motives and each of the four types of NMPD use.  Given that conformity motives are 
conceptualized as being driven by negative reinforcement from an external source, no 
differences were expected based on NMPD type.  Finally, self-medication motives were 





between self-medication and stimulant use.  Again, this is consistent with the study’s 
theoretically driven hypotheses.  Self-medication motives are conceptualized as being driven by 
negative reinforcement from an internal source.  As such, opioids, tranquilizers, and sedatives 
were expected to demonstrate stronger relations (compared to stimulants) with self-medication 
motives given the pharmacological purpose of these drug types. 
Concurrent validity was supported for the NMPD Motives Questionnaire based upon an 
examination of the relations between NMPD motives and NMPD use and NMPD-related 
problems.  Specifically, social/recreation, performance, and self-medication motives were 
associated with a high frequency of NMPD use.  In addition, social/recreation and self-
medication motives demonstrated a strong relation with NMPD-related problems, while 
performance and conformity motives only demonstrated a small linkage to NMPD-related 
problems.  As expected, all NMPD motives were generally associated with past 6-month licit 
(i.e., alcohol, tobacco) and illicit (i.e., marijuana, cocaine, hallucinogen, ecstasy) substance use. 
In fact, one of the most consistent correlates of NMPD use among both adolescents and 
emerging adults is the use of alcohol and other drugs (Arria, Caldeira, Vincent, O’Grady, & 
Wish, 2008; Barrett et al., 2005; McLarnon, Barrett, Monaghan, & Stewart, 2012).  Consistent 
with previous research examining substance use motives (Cooper, 1994; Patrick, Lee, & 
Larimer, 2011; Simons et al., 2000), conformity motives for NMPD use demonstrated small 
associations with NMPD use and problems.  
In support of incremental validity, additional analyses revealed that NMPD motives are 
useful constructs for understanding both NMPD use and NMPD-related problems. Specifically, 
NMPD motives contributed unique variance (12%) to the prediction of NMPD use after 





Social/recreation, performance, and self-medication motives were significant positive predictors 
of NMPD use, with social/recreation motives being the strongest of the three.  Conformity 
motives were not a unique predictor of NMPD use.  Finally, NMPD motives also contributed 
unique variance (7%) to the prediction of NMPD-related problems after accounting for the 
influence of age, gender, race, and NMPD use.  As expected, NMPD use remained the strongest 
predictor of NMPD-related problems.  However, after accounting for NMPD use, self-
medication motives remained a significant positive predictor of NMPD-related problems.  As 
such, individuals reporting self-medication motives for NMPD use may be at an increased risk of 
experiencing NMPD-related problems, compared to those who report social/recreation, 
performance, or conformity motives.  This finding is consistent with the drinking motives 
literature where coping motives have consistently been associated with alcohol problems (e.g., 
Cooper, 1994; Cooper et al, 1995; Kuntsche, Knibbe, Gmel, & Engels, 2005; Simons et al, 
2000).  In addition, this finding is also consistent with the NMPD use literature where self-
medication motives (e.g., to get away from my problems or troubles) have been associated with 
substance-related problems (e.g., Boyd et al., 2006; McCabe et al., 2007). 
 Consistent with Cox and Klinger’s motivational model of substance use, data from the 
current study also generally support two underlying dimensions (i.e., valence and source) across 
motives for NMPD use.  Specifically, negative reinforcement motives (conformity and self-
medication) share several characteristics that distinguish them from positive reinforcement 
motives, such as relation to negative affect, coping drinking motives, and conformity drinking 
motives.  Of note, it was originally hypothesized that performance motives would be captured 
within a broader self-medication category and be driven by negative reinforcement from an 





positive reinforcement (e.g., to produce favorable performance outcomes or enhance 
productivity) than negative reinforcement (e.g., to reduce inattention).  This is further supported 
by shared characteristics with other positive reinforcement motives, such as positive affect, 
enhancement drinking motives, and social drinking motives.  
When considering the second dimension (internal versus external source), data from the 
current study highlights some of the complexities of NMPD use.  As expected, data from the 
current study supports the conceptualization of NMPD motives driven by negative reinforcement 
as coming from different sources, namely: conformity motives (external source) and self-
medication motives (internal source).  Interestingly, NMPD motives driven by positive 
reinforcement (i.e., social/recreation and performance) appear to reflect a mix of internal and 
external sources of reinforcement. For example, social/recreation motives include items such as: 
“because it gives you a pleasant feeling” (internal source) and “because it improves parties or 
celebrations” (external source).  Similarly, performance motives include items such as: “to help 
focus” (internal source) and “to perform better on school work and tests” (external source).  One 
possible explanation for these motives to include mixed sources may be related to the differing 
pharmacological effects based on the type of NMPD. Another possible explanation relates to the 
fact that a distinct social factor did not emerge within the factor structure.  In fact, the majority of 
items included in the social/recreation subscale reflect enhancement-related motives (e.g. “to get 
high”) rather than social-related motives (e.g., “to be sociable”).  Moreover, the enhancement-
related items demonstrated higher item loadings compared to the social-related items (see Table 
4).  This finding may suggest that NMPD use is a less “social” behavior compared to drinking or 





drinking or smoking marijuana might take place over a longer period of time with other people. 
Strengths, Limitations, and Future Directions 
The present study has several important strengths which should be noted.  First, a large 
sample (N = 423) of emerging adult NMPD users were successfully recruited from a broader 
study of college student substance use behaviors and attitudes. Evidence suggests that sample 
sizes of at least 300 participants are generally sufficient for ensuring stability and replicability of 
factor analyses (Clark & Watson, 1995; Tabachnick, Fidell & Osterlind, 2001; Worthington & 
Whittaker, 2006).  As such, the current study exceeded the target number of participants (i.e., 
300) to ensure adequate power.  Second, this is the first known study to develop a 
psychometrically sound measure of NMPD motives.  Two previous studies have developed 
measures to examine motives for opioid use (i.e., Opioid Prescription Medication Motives 
Questionnaire; Jones, Spradlin, Robinson, & Tragesser, 2014) and expectancies related to 
stimulant use (i.e., Prescription Stimulant Expectancy Questionnaire; Looby & Earlywine, 2009); 
however, these measures are limited to specific drug types.  As such, the NMPD Motives 
Questionnaire provides a psychometrically sound instrument that is able to capture motives 
across all four NMPD types (opioids, stimulants, sedatives, and tranquilizers) and provides a 
common language for researchers who seek to examine specific motive dimensions related to the 
use of NMPDs.  Of note, the items in the aforementioned measures were not considered in the 
development of the current NMPD Motives Questionnaire.  One measure (i.e., the Opioid 
Prescription Medication Motives Questionnaire) was developed after the current study started 
and the other measure (i.e., the Prescription Stimulant Expectancy Questionnaire) was not 
identified until after the current measure was developed.  A comparison of the developed scales 





Specifically, the Prescription Stimulant Expectancy Questionnaire includes items that target both 
positive and negative expectancies for nonmedical stimulant use across several general domains, 
including focus (e.g., “I can focus very well”, “I focus on unimportant tasks”), school 
performance (e.g., “I learn very efficiently”, “I feel like I’m cutting corners to do well”), and 
physiological responses (e.g., “It’s no trouble to sit still”, “I feel twitchy”).  These domains were 
also captured in the development of the motives measure in the present study (e.g., “to help 
focus” and “to perform better on school work or tests”).  Similarly, the Opioid Prescription 
Medication Motives Questionnaire was based upon previous prescription opioid motives 
literature (e.g., Boyd et al., 2006; Lord et al., 2011; McCabe et al., 2007), which were also 
considered for the current item generation.  Jones and colleagues (2014) reported a four-factor 
model of the measure, including social (e.g., “because it improves parties or celebrations”), 
enhancement (e.g., “to get high”), coping (e.g., “to forget about your problems”), and pain (e.g., 
“to relieve physical pain”).  Again, similar items were included in the development of the 
motives measure in the present study.  Therefore, while these measures were not considered 
during the initial item generation for the current study, an examination of items suggest 
overarching similarities in the motives and expectancies identified.  As such, the NMPD Motives 
Questionnaire is judged to reflect the current state of the NMPD motives literature.  Finally, the 
present study has important utility and implications for both clinical and research domains.  The 
NMPD Motives Questionnaire is a theoretically-based, brief, and reliable measure of NMPD 
motives that demonstrates preliminary evidence of sound construct validity.   
Within the current study, there are also a few limitations that should be considered.  First, 
while the study demonstrated the NMPD Motives Questionnaire exhibits good construct validity, 





studies should include additional tests of validity and reliability to provide further support of the 
psychometric properties of this instrument.  For example, future studies may further assess the 
validity of this measure by examining the strength of the association between motives and 
diagnosis of an NMPD use disorder.  In addition, this was a preliminary study which 
appropriately utilized an exploratory factor analyses.  Future studies should explore the 
psychometric properties of the NMPD Motives questionnaire using confirmatory factor analyses 
within an independent sample.   
Second, the generalizability of the current results is limited given the majority of the 
sample identified as women (62%) and either White non-Hispanic (53%) or White Hispanic 
(28%).  As such, additional research is needed to understand the degree to which the current 
results generalize to other populations.  Future research should attempt to examine the NMPD 
Motives Questionnaire in a more diverse sample.  Additionally, data analyses did not examine or 
control for potential differences based on data collection site.  Importantly, site differences can 
lead to misinterpretation of results due to systematic bias within the data and thus increase the 
possibility of Type II error.  Follow-up examination of the data revealed some notable site 
differences.  Specifically, participants reporting lifetime NMPD use at the University of 
Arkansas (n = 241; Mage= 19.3; 56% women) were younger, more likely to report NMPD 
performance motives and social drinking motives compared to participants at the University of 
North Texas.  Further, participants at the University of North Texas (n = 182; Mage= 20.8; 70% 
women) were significantly older, more likely to report NMPD social/recreation motives, NMPD 
self-medication motives, and present moment negative affect compared to individuals at the 
University of Arkansas.  Although not presented in the present document, follow-up analyses 





Third, the study is limited in that it is based on self-report data among college students in 
a cross-sectional design.  Given the self-report nature, the sample could have inaccurately 
portrayed their motives for NMPD use or actual NMPD use behaviors.  Moreover, the cross-
sectional design utilized is not able to address issues of directionality or developmental change 
over time.  Longitudinal studies are necessary in order to better understand the trends in motives 
and correlates of NMPD use among emerging adult samples.  In addition, while college-based 
samples are an important population to examine regarding substance use behaviors, findings 
should be interpreted with caution before generalizing to the larger population (Tanner, 2006).   
Fourth, the current study included a sample of individuals who reported any lifetime 
NMPD use.  Previous studies have suggested that individuals who endorse three or more 
occasions of NMPD use in the past month are less likely to report experimental use and 
consequently more likely to demonstrate drug-use related problems (McCabe & Teter, 2007).  
Given the aim of the current study, a restricted sample would limit the generalizability of the 
findings.  College has been identified as a high-risk time for the initiation of substance use 
behaviors that develop into more problematic use over time (McCabe et al., 2007; SAMHSA, 
2014).  As such, the inclusion of individuals who have used NMPD one or two times is 
important to better understand the full spectrum of use from initiation to more problem use. 
Fifth, an experimenter error was made in the questionnaire administered to students at 
one of the data collection sites, resulting in incomplete data from this site related to NMPD 
problems.  Consequently, all analyses that included the Short Inventory of Problems – PDM 
were limited to data collected at the University of Arkansas (n = 241).  Also, positive and 
negative affect were assessed at the present moment rather than over the past 6-months or longer 





substance use motives and affect, given the moment the individual completed the study is likely 
unrepresentative of his/her general affective state.  Finally, novelty and intensity sensation 
seeking were measured using a modified set of items rather than the original AISS scale.  While 
this decision increased reliability of this measure in the current study, it also limited the ability 
for direct comparison with other studies related to sensation seeking.  
Conclusions 
The current study extends previous research on motives for NMPD use by developing 
and validating a comprehensive NMPD motives measure.  As NMPD use continues to rise, it is 
important that both researchers and clinicians are better able to not only identify this high-risk 
population but also provide support and services that map on to the complex presentation that 
these individuals are likely to experience.  Similar to other substance use motives (Cooper, 1994; 
Cooper, Russell, Skinner, & Windle, 1992; Simons et al., 1998), results of the current study 
suggest that individuals engage in NMPD use for a variety of reasons.  As such, a better 
understanding of NMPD motives is necessary in order to gain insight into NMPD use behavior 
and its consequences.  Taken together, results of this study support the NMPD Motives 
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Table 1. Demographic Summary 
 
Total Sample 
(N = 1,427) 
NMPD Use Sample 
(n = 423) 
   Age (M, SD) 19.83 (SD = 1.71) 19.94 (SD = 1.75) 
   Gender 
  
 
Female 934 (65.5%) 262 (61.9%) 
 
Male 492 (34.5%) 161 (38.1%) 
   Race/Ethnicity 
  
 
White Non-Hispanic 678 (48.5%) 224 (53.0%) 
 
White Hispanic 366 (26.2%) 120 (28.4%) 
 
African American / Black  149 (10.7%) 28 (6.6%) 
 
Hispanic/Latino (non-White) 63 (4.5%) 19 (4.5%) 
 
Asian, American Indian, Pacific 
Islander 110 (7.8%) 20 (4.7%) 
 




   Year in College 
  
 
Freshman 613 (43.0%) 168 (39.7%) 
 
Sophomore 364 (25.5%) 112 (26.5%) 
 
Junior 278 (19.5%) 90 (21.3%) 
 
Senior 171 (12.0%) 53 (12.5%) 




Single/Never Married 1,405 (98.5%) 416 (98.3%) 
 
Married 16 (1.1%) 6 (1.4%) 
 
Separated 2 (0.1%) 0 (0.0%) 
 
Divorced 1 (0.1%) 0 (0.0%) 
   Living Conditions 
  
 
Residence Hall 655 (45.9%) 168 (39.7%) 
 
Apartment 491 (34.4%) 159 (37.6%) 
 
Greek Housing 36 (2.5%) 20 (4.7%) 
 
Own Home 56 (3.9%) 22 (5.2%) 
 
With Parents/Family 159 (11.1%) 48 (11.3%) 
 





   
   Employment 
  
 
Unemployed 836 (58.6%) 235 (55.6%) 
 
Part-time (1-20 hrs/week) 374 (26.2%) 105 (24.8%) 
 
Part-time (20-30 hrs/week) 160 (11.2%) 63 (14.9%) 
 
Full-time 52 (3.6%) 18 (4.3%) 






Table 2. Lifetime and Past 6-month NMPD use by drug type (N = 423) 
 
Lifetime NMPD use  Past 6-month NMPD use 
  
   
Opioids 
 
   
 
Never 150 (35.6%)  Never 279 (66.4%) 
 
1-3 times 132 (31.4%)  Less than monthly 106 (25.2%) 
 
4-6 times 36 (8.5%)  Monthly 19 (4.5%) 
 
7-10 times 41 (9.7%)  Weekly 11 (2.6%) 
 
11-20 times 24 (5.7%)  Daily/Almost Daily 5 (1.2%) 
 
21-40 times 19 (4.5%)    
 




   
Stimulants 
 
   
 
Never 111 (26.3%)  Never 203 (48.2%) 
 
1-3 times 110 (26.1%)  Less than monthly 133 (31.6%) 
 
4-6 times 55 (13.0%)  Monthly 59 (14.0%) 
 
7-10 times 55 (13.0%)  Weekly 22 (5.2%) 
 
11-20 times 41 (9.7%)  Daily/Almost Daily 4 (1.0%) 
 
21-40 times 25 (5.9%)    
 
41+ times 25 (5.9%)    
  
   
Sedatives 
 
   
 
Never 283 (67.5%)  Never 359 (85.3%) 
 
1-3 times 73 (17.4%)  Less than monthly 47 (11.2%) 
 
4-6 times 23 (5.5%)  Monthly 12 (2.9%) 
 
7-10 times 18 (4.3%)  Weekly 2 (0.5%) 
 
11-20 times 12 (2.9%)  Daily/Almost Daily 1 (0.2%) 
 
21-40 times 7 (1.7%)    
 
41+ times 3 (0.7%)    
  
   
Tranquilizers 
 
   
 
Never 271 (64.4%)  Never 347 (82.4%) 
 
1-3 times 66 (15.7%)  Less than monthly 49 (11.6%) 
 
4-6 times 24 (5.7%)  Monthly 17 (4.0%) 
 
7-10 times 19 (4.5%)  Weekly 6 (1.4%) 
 
11-20 times 15 (3.6%)  Daily/Almost Daily 2 (0.5%) 
 
21-40 times 17 (4.0%)    
 
41+ times 9 (2.1%)    





Table 3. Principle Components Analysis of the 55-item NMPD Motives Questionnaire: Oblimin 
Rotated Factor Loadings (Pattern Matrix) for Motives in the NMPD Use Sample (N = 423) 










     
Eigenvalues 24.43 5.82 3.62 2.61 
Variance explained (%) 44.42 10.58 6.58 4.75 
Chronbach’s alpha 0.97 0.94 0.92 0.95 
     
NMPD Motives Questionnaire item 
content 
    
18. Because it’s fun .925    
11. Because it makes social gatherings 
more fun 
.899    
14. Because it improves parties and 
celebrations 
.889    
16. To celebrate a special occasion with 
friends 
.844    
10. To get high .831    
13. Because it gives you a pleasant 
feeling 
.824    
9. Because it’s exciting  .798    
7. Because you like the feeling  .790    
3. Because it helps you enjoy a party .787    
5. To be sociable .764    
25. To be more open to experiences .726    
26. Because you want to alter your 
perspective 
.679    
15. Because you feel more self-confident 
and sure of yourself 
.607    
47. To relieve boredom  .601    
33. To take my high to the next level .596    
48. To stay out and party longer .594    
41. Because you had nothing better to do  .587  .317  
23. To understand things differently .569    
22. Because it helps me be more creative 
and original 
.527    
36. Because it makes you more 
comfortable in an unfamiliar situation 
.507    
24. To expand my awareness .500 .387   
55. To allow you to think differently   .437    
21. To know myself better  .393  .348  





39. To perform better on school work or 
on tests 
 .920   
44. To help you study   .918   
30. To help you concentrate  .925   
40. Because it helps to increase your 
alertness 
 .851   
32. To be more efficient   .846   
51. To stay awake  .769   
38. To help you stay organized  .761   
34. To feel more energetic  .365 .483   
8. So that others won’t kid you about not 
doing it 
  .944  
49. Because you didn’t want to be the 
only one not doing it 
  .872  
20. So you won’t feel left out    .822  
19. To be liked   .783  
2. Because your friends pressure you to 
use them 
  .755  
50. Because it counteracts the effects of 
other drugs 
  .720  
42. To avoid withdrawal from alcohol or 
other drugs 
  .707  
12. To fit in with the group you like   .664  
31. To lose weight   .534  
52. To reduce fatigue during exercise  .314 .462  
46. To suppress your appetite   .346 .379  
29. To manage pain    .848 
43. To help you sleep    .792 
37. Because it relieves your pain    .787 
54. Because you are having problems 
sleeping 
   .769 
4. Because it helps you when you feel 
depressed or nervous 
   .731 
35. To escape from your life    .722 
27. To calm down    .717 
17. To forget about your problems     .671 
28. Because it helps you deal with stress    .661 
1. To forget your worries    .652 
6. To cheer up when you are in a bad 
mood 
.399   .536 
53. Because it helps make napping easier 
and enjoyable  
   .424 






Table 4. Principle Components Analysis of the 20-item NMPD Motives Questionnaire: Oblimin 
Rotated Factor Loadings (Pattern Matrix) for Motives in the NMPD Use Sample (N = 423) 










     
Eigenvalues 8.15 3.39 2.24 1.30 
Variance explained (%) 40.75 16.97 11.19 6.47 
Chronbach’s alpha 0.93 0.93 0.90 0.89 
     
NMPD Motives Questionnaire item 
content 
    
18. Because it’s fun .903    
10. To get high .865    
13. Because it gives you a pleasant 
feeling 
.856    
14. Because it improves parties and 
celebrations 
.846    
5. To be sociable .754    
39. To perform better on school work or 
on tests 
 .939   
45. To help focus   .910   
40. Because it helps to increase your 
alertness 
 .887   
32. To be more efficient   .862   
38. To help you stay organized  .798   
8. So that others won’t kid you about not 
doing it 
  .939  
49. Because you didn’t want to be the 
only one not doing it 
  .899  
2. Because your friends pressure you to 
use them 
  .816  
19. To be liked   .760  
50. Because it counteracts the effects of 
other drugs 
  .725  
29. To manage pain    .865 
43. To help you sleep    .783 
35. To escape from your life    .744 
4. Because it helps you when you feel 
depressed or nervous 
   .706 
17. To forget about your problems     .700 






Table 5. Principle Components Analysis of the Arnett Inventory of Sensation Seeking: Varimax 
Rotated Factor Loadings (N = 423) 




   
Eigenvalues 2.57 1.50 
Variance explained (%) 23.38 13.58 
Chronbach’s alpha 0.60 0.52 
   
AISS item content   
9. I would like to travel to places that are strange and far away .732  
1. I can see how it would be interesting to marry someone from a 
foreign country 
.648  
11. I would have enjoyed being one of the first explorers of an 
unknown land 
.594 .370 
19. If it were possible to visit another planet or the moon for free, I 
would be among the first in line to sign up 
.530 .410 
17. I think it’s best to order something familiar when eating in a 
restaurant 
.443  
5. When I am taking a trip, I think it is best to make as few plans as 
possible and just take it as it comes 
.407  
20. I can see how it must be exciting to be in a battle during way  .727 
16. It would be interesting to see a car accident happen  .649 
12. I like a movie where there are a lot of explosions and car chases  .562 
18. I like the feeling of standing next to the edge on a high place and 
looking down 
.361 .489 
8. If I were to go to an amusement park, I would prefer to ride the 
rollercoaster or other fast rides 
 .316 









Table 6. Correlation Matrix  
 
M SD 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1. NMPD - Social/Rec 2.10 1.23 -- 
      
       
2. NMPD -Performance 2.35 1.33 .21** -- 
     
       
3. NMPD - Conformity 1.23 0.58 .44** .24** -- 
    
       
4. NMPD - Self-Med 1.86 1.05 .66** .24** .50** -- 
   
       
5. DMQ- Social 3.32 1.04 .26** .30** .11* .16** -- 
  
       
6. DMQ- Coping 2.26 0.96 .26** .22** .26** .44** .51** -- 
 
       
7. DMQ- Enhancement 2.99 1.05 .34** .26** .15** .23** .72** .54** --        
8. DMQ- Conformity 1.59 0.78 .18** .17** .44** .28** .36** .49** .29** --       
9. DUDIT-E - positive  23.78 16.65 .55** .30** .31** .55** .24** .39** .29** .25** --      
10. Positive Affect 23.71 8.68 .09 .12* .09 .05 .09 .06 .17** .12* .16** --     
11. Negative Affect 15.81 6.88 .14** .14** .29** .32** .61 .32** .11* .22** .27** .10 --    
12. Novelty SS 27.44 4.05 .13** .08 .02 .08 -.02 -.04 .06 -.01 .25** .08 .02 --   
13. Intensity SS 27.17 4.09 .14** .09 .04 .06 .09 .01 .16** .02 .13* .11 -.03 .31** --  
14. Age 19.94 1.75 .14** -.02 .11* .16** -.03 .01 -.01 .05 .04 .08 .03 .04 -.08 -- 
Note. 
*
 p < .05, 
**
 p < .01. NMPD = Nonmedical Prescription Drug, NMPD-Social/Rec = Social/Recreation motives, NMPD – Self-











Table 7. Correlation Matrix (N = 423) 
 
1 2 3 4 5 6 7 8 9 10 11 
1. NMPD - Social/Rec -- 
      
    
2. NMPD -Performance .21
**
 -- 
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 --   
10. Gender (0 = men, 1 = women) -.14
**






 .02 --  











 p < .05, 
**
 p < .01. NMPD = Nonmedical Prescription Drug, NMPD-Social/Rec = Social/Recreation motives, NMPD – Self-












Table 8. Correlation Matrix (N = 423) 
 
M SD 1 2 3 4 5 6 7 8 9 10 11 12 
1. NMPD - Social/Rec 2.10 1.23 -- 
      
     
2. NMPD -Performance 2.35 1.33 .21
**
 -- 
     
     





    
     







   
     

























     










 --      
8. Past 6-month Tobacco use 2.16 1.39 .39
**








 --     
















 --    


















 --   




















 --  

























 p < .05, 
**
 p < .01.  NMPD = Nonmedical Prescription Drug, NMPD-Social/Rec = Social/Recreation, NMPD – Self-Med = 
NMPD Self-Medication. 
a
 n = 241, due to an experimenter error made in the questionnaire administered to students at the University 
of North Texas data collection site, all analyses that included this measure (i.e., Short Inventory of Problems – Prescription Drug 
Misuse) were limited to data collected at the University of Arkansas.  Lifetime heroin, methamphetamine, and PCP use were not 





Table 9. Hierarchical Linear Regression Predicting Lifetime Nonmedical Prescription Drug Use 
from NMPD Motives. 
Note. NMPD = Nonmedical Prescription Drug. Lifetime heroin, methamphetamine, and PCP use 












 B SE beta t p 
Block 1      
   Age .508 .11 .196 4.75 < .001 
   Gender (0 = men, 1 = women)
 
 .021 .41 .002 .05 .96 
   Race (0 = non-white, 1 = white) .200 .50 .017 .403 .69 
   Past 6-month Alcohol Use  -.089    .21 -.019 -.423 .67 
   Past 6-month Cigarette Use .575 .16 .175 3.65 < .001 
   Past 6-month Marijuana Use .575 .15 .190 3.76 < .001 
   Past 6-month Cocaine Use 3.48 .63 .326 5.57 < .001 
   Past 6-month Hallucinogen Use .335 .51 .038 .657 .51 
   Past 6-month Ecstasy Use .161 .66 .015 .243 .81 
      
Block 2       
   NMPD – Social/Recreation Motives .988 .21 .268 4.71 < .001 
   NMPD – Performance Motives .605 .14 .178 4.42 < .001 
   NMPD – Conformity Motives -.187 .36 -.024 -.516 .61 
   NMPD – Self-medication Motives .462 .23 .107 1.98 < .05 




Table 10. Hierarchical Linear Regression Predicting Nonmedical Prescription Drug Use 
Problems from NMPD Motives. 














 B SE beta t p 
Block 1      
   Age .021 .08 .015 .263 .79 
   Gender (0 = men, 1 = women)
 
 .106 .29 .021 .371 .71 
   Race (0 = non-white, 1 = white) .273 .36 .043 .760 .45 
   NMPD use  .277 .03 .517 8.90 < .001 
      
Block 2       
   NMPD – Social/Recreation Motives .128 .16 .065 .811 .42 
   NMPD – Performance Motives -.001 .11 .000 -.005 .99 
   NMPD – Conformity Motives -.018 .27 -.004 -.068 .95 
   NMPD – Self-medication Motives .590 .18 .256 3.32 < .001 
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NMPD Motives Questionnaire 
Below is a list of reasons people sometimes give for nonmedical prescription drug use. Thinking 
about all of the times that you have used prescription drugs nonmedically and indicate how often 














1. To forget your worries 1 2 3 4 5 
2. Because your friends pressure 
you to use them 
1 2 3 4 5 
3. Because it helps you enjoy a 
party 
1 2 3 4 5 
4. Because it helps you when 
you feel depressed or nervous 
1 2 3 4 5 
5. To be sociable 1 2 3 4 5 
6. To cheer up when you are in 
a bad mood 
1 2 3 4 5 
7. Because you like the feeling 1 2 3 4 5 
8. So that others won’t kid you 
about not doing it 
1 2 3 4 5 
9. Because it’s exciting 1 2 3 4 5 
10. To get high 1 2 3 4 5 
11. Because it makes social 
gatherings more fun 
1 2 3 4 5 
12. To fit in with a group you 
like 
1 2 3 4 5 
13. Because it gives you a 
pleasant feeling 
1 2 3 4 5 
14. Because it improves parties 
and celebrations 
1 2 3 4 5 
15. Because you feel more self-
confident and sure of yourself 
1 2 3 4 5 
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16. To celebrate a special 
occasion with friends 
1 2 3 4 5 
17. To forget about your 
problems 
1 2 3 4 5 
18. Because it’s fun 1 2 3 4 5 
19. To be liked 1 2 3 4 5 
20. So you won’t feel left out 1 2 3 4 5 
21. To know myself better 1 2 3 4 5 
22. Because it helps me be more 
creative and original 
1 2 3 4 5 
23. To understand things 
differently 
1 2 3 4 5 
24. To expand my awareness 1 2 3 4 5 
25. To be more open to 
experiences 
1 2 3 4 5 
26. Because you want to alter 
your perspective 
1 2 3 4 5 
27. To calm down 1 2 3 4 5 
28. Because it helps you deal 
with stress 
1 2 3 4 5 
29. To manage pain 1 2 3 4 5 
30. To help you concentrate 1 2 3 4 5 
31. To lose weight 1 2 3 4 5 
32. To be more efficient 1 2 3 4 5 
33. To take my high to the next 
level 
1 2 3 4 5 
34. To feel more energetic 1 2 3 4 5 
35. To escape from your life 1 2 3 4 5 
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36. Because it makes you more 
comfortable in an unfamiliar 
situation 
1 2 3 4 5 
37. Because it relieves your pain 1 2 3 4 5 
38. To help you stay organized 1 2 3 4 5 
39. To perform better on school 
work or on tests 
1 2 3 4 5 
40. Because it helps to increase 
your alertness 
1 2 3 4 5 
41. Because you had nothing 
better to do 
1 2 3 4 5 
42. To avoid withdrawal from 
alcohol or other drugs 
1 2 3 4 5 
43. To help you sleep 1 2 3 4 5 
44. To help you study 1 2 3 4 5 
45. To help focus 1 2 3 4 5 
46. To suppress your appetite 1 2 3 4 5 
47. To relieve boredom 1 2 3 4 5 
48. To stay out and party longer 1 2 3 4 5 
49. Because you didn’t want to 
be the only one not doing it 
1 2 3 4 5 
50. Because it counteracts the 
effects of other drugs 
1 2 3 4 5 
51. To stay awake 1 2 3 4 5 
52. To reduce fatigue during 
exercise 
1 2 3 4 5 
53. Because it helps make 
napping easier and enjoyable 
1 2 3 4 5 
54. Because you are having 
problems sleeping 
1 2 3 4 5 
55. To allow yourself to think 
differently 




Drinking Motives Questionnaire-Revised 
Below is a list of reasons people sometimes give for drinking alcohol. Thinking about all of the times 

















1. To forget your worries 1 2 3 4 5 
2. Because your friends pressure you 
to drink 
1 2 3 4 5 
3. Because it helps you enjoy a party 1 2 3 4 5 
4. Because it helps you when you feel 
depressed or nervous 
1 2 3 4 5 
5. To be sociable 1 2 3 4 5 
6. To cheer up when you are in a bad 
mood 
1 2 3 4 5 
7. Because you like the feeling 1 2 3 4 5 
8. So that others won’t kid you about 
not drinking 
1 2 3 4 5 
9. Because it’s exciting 1 2 3 4 5 
10. To get high, buzzed, or drunk 1 2 3 4 5 
11. Because it makes social gatherings 
more fun 
1 2 3 4 5 
12. To fit in with a group you like 1 2 3 4 5 
13. Because it gives you a pleasant 
feeling 
1 2 3 4 5 
14. Because it improves parties and 
celebrations 
1 2 3 4 5 
15. Because you feel more self-
confident and sure of yourself 
1 2 3 4 5 
16. To celebrate a special occasion 
with friends 
1 2 3 4 5 
17. To forget about your problems 1 2 3 4 5 
18. Because it’s fun 1 2 3 4 5 
19. To be liked 1 2 3 4 5 
20. So you won’t feel left out. 1 2 3 4 5 
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Drug Use Disorders Identification Test – Extended  






Somewhat A lot Totally 
1. Sleep better 1 2 3 4 5 
2. Lose tension and become relaxed 1 2 3 4 5 
3. Become happy 1 2 3 4 5 
4. Become strong 1 2 3 4 5 
5. Feel “normal” 1 2 3 4 5 
6. Become creative (get ideas, do artistic 
things) 
1 2 3 4 5 
7. Become active (clean home, do dishes, wash 
car, etc.) 
1 2 3 4 5 
8. Love everybody and the whole world 1 2 3 4 5 
9. More self-confidence 1 2 3 4 5 
10. Feel less pain in my back, neck, head, etc. 1 2 3 4 5 
11. Get a feeling that everything will work out 1 2 3 4 5 
12. Life without drugs is boring 1 2 3 4 5 
13. Because it gives you a pleasant feeling 1 2 3 4 5 
14. I can control feelings like anxiety, anger, 
and depression 
1 2 3 4 5 
15. With drugs I feel that I am part of the group 1 2 3 4 5 
16. I get better contact with others 1 2 3 4 5 





Nonmedical Prescription Drug Use 
 
1. Have you ever used a prescription drug that was not prescribed to you, or used it in ways for 
which it was not prescribed? 
a. Yes 
b. No 
2. On how many occasions in your lifetime have you used the following types of prescription 





















Pain medication  
 
(e.g., opioids such as  
Vicodin®, OxyContin®, 
Tylenol 3® with codeine, 
Percocet®, Darvocet®, 
morphine, hydrocodone, and 
oxycodone) 
       
Stimulant medication  
 
(e.g., Ritalin®, Dexedrine®, 
Adderall®, Concerta®, 
methlyphenidate) 
       
Sleep medication  
 
(e.g., Ambien®, Halcion®, 
Restoril®, temazepam, and 
triazolam) 




(e.g., Ativan®, Xanax®, 
Valium®, Klonopin®, 
diazepam, and lorazepam) 
       
More than one of these 
prescription drugs at the 
same time  
 
(e.g., mixing two or more 
types of prescription drugs) 
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3. On how many occasions in the past 6-months have you used the following types of prescription 












(e.g., opioids such as  
Vicodin®, OxyContin®, 










     
Sleep medication 
(e.g., Ambien®, Halcion®, 
Restoril®, temazepam, and 
triazolam) 
     
Sedative/Anxiety 
medication (e.g., Ativan®, 
Xanax®, Valium®, 
Klonopin®, diazepam, and 
lorazepam) 
     
More than one of these 
prescription drugs at the 
same time 
(e.g., mixing two or more 
types of prescription drugs) 
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4. How old were you when you first started using [NMPD type]? _______ 
 







6. In which situation do you most often take [NMPD] for nonmedical purposes? 
a. With a friend or acquaintance 
b. With a family member or other relative 
c. By yourself 
 
7. Have you ever consumed alcohol while experiencing the effects of a prescription drug 





8. How often in the past 6-months have you used a prescription drug (i.e., pain medication, 
















Short Inventory of Problems – Prescription Drug Misuse 
 
Here are a number of events that people sometimes experience.  Read each one carefully, and 
circle the number that indicates whether this has EVER happened to you (0 = No, 1 = Yes).  If an 
item does not apply to you, circle zero (0). 
Has this EVER happened to you? 
Circle one answer: 
No Yes 
1. I have been unhappy because of my prescription drug 
misuse. 
0 1 
2. Because of my prescription drug misuse, I have not eaten 
properly. 
0 1 
3. I have failed to do what is expected of me because of my 
prescription drug misuse. 
0 1 
4. I have felt guilty or ashamed because of my prescription 
drug misuse. 
0 1 
5. I have taken foolish risks when I have misused prescription 
drugs. 
0 1 
6. When misusing prescription drugs, I have done impulsive 
things that I regretted later. 
0 1 
7. My physical health has been harmed by my prescription 
drug misuse. 
0 1 
8. I have had money problems because of my prescription 
drug misuse. 
0 1 
9. My physical appearance has been harmed by my 
prescription drug misuse. 
0 1 
10. My family has been hurt by my prescription drug misuse. 0 1 
11. A friendship or close relationship has been damaged by my 
prescription drug misuse. 
0 1 
12. My prescription drug misuse has gotten in the way of my 
growth as a person. 
0 1 
13. My prescription drug misuse has damaged my social life, 
popularity, or reputation. 
0 1 
14. I have spent too much or lost a lot of money because of my 
prescription drug misuse. 
0 1 






Positive and Negative Affect Schedule 
 
This scale consists of a number of words that describe different feelings and emotions.  Read 
each item and then mark the appropriate answer in the space next to that word.  Indicate to what 
extent you feel this way right now, that is, at the present moment.  Use the following scale to 
record your answers.   
 
 1  2  3  4  5 
very slightly         a little     moderately      quite a bit     extremely 
 
 
 ____interested    ____irritable 
  
____distressed   ____alert 
 
____excited    ____ashamed 
 
____upset    ____inspired 
 
____strong    ____nervous 
 
____guilty    ____determined 
 
____scared    ____attentive 
 
____hostile    ____jittery 
 
____enthusiastic   ____active 
 







Substance Use Questionnaire 
Please indicate how many days you have used each of the following substances in the past 6 months. Also, please indicate if you 
have EVER used the substance in your lifetime. (CHECK THE APPROPRIATE BOX FOR EACH QUESTION.) 
 
How often did you use this substance in the PAST 6 MONTHS? 
Have you EVER 
used this substance 
in your lifetime?  
 Never 
Less than 
monthly Monthly Weekly 
Daily/ 
Almost daily Yes No 
a. Alcohol 1 2 3 4 5 1 2 
b. Caffeine (coffee, tea, caffeinated cola, etc.) 1 2 3 4 5 1 2 
c.  Cigarettes or other tobacco 1 2 3 4 5 1 2 
d.  Marijuana, hashish (pot, grass) 1 2 3 4 5 1 2 
e.  Cocaine (coke, crack, rock)  1 2 3 4 5 1 2 
f.  Heroin 1 2 3 4 5 1 2 
g.  Methamphetamine (crank, meth, ice) 1 2 3 4 5 1 2 
h. Hallucinogens (LSD, mescaline, peyote, 
mushrooms, psilocybin, etc.) 1 2 3 4 5 1 2 
i.  PCP (angel dust) or Ketamine (“K”) 1 2 3 4 5 1 2 
j. Ecstasy (X), GHB (Liquid X), or Rohypnol 




Arnett Inventory of Sensation Seeking 
  
For each item, indicate which response best applies to you. 
 
1. I can see how it would be interesting to marry someone from a foreign country. 
(A) describes me very well 
(B) describes me somewhat 
(C) does not describe me very well 
(D) does not describe me at all 
 
2. When the water is very cold, I prefer not to swim even if it is a hot day. 
(A) describes me very well 
(B) describes me somewhat 
(C) does not describe me very well 
(D) does not describe me at all 
 
3. If I have to wait in a long line, I’m usually patient about it. 
(A) describes me very well 
(B) describes me somewhat 
(C) does not describe me very well 
(D) does not describe me at all 
 
4. When I listen to music, I like it to be loud. 
(A) describes me very well 
(B) describes me somewhat 
(C) does not describe me very well 
(D) does not describe me at all 
 
5. When I am taking a trip, I think it is best to make as few plans as possible and just take it as it 
comes. 
(A) describes me very well 
(B) describes me somewhat 
 (C) does not describe me very well 
 (D) does not describe me at all 
 
6. I stay away from movies that are said to be frightening or highly suspenseful. 
(A) describes me very well 
(B) describes me somewhat 
 (C) does not describe me very well 




7. I think it’s fun and exciting to perform or speak before a group. 
(A) describes me very well 
(B) describes me somewhat 
 (C) does not describe me very well 
 (D) does not describe me at all 
 
8. If I were to go to an amusement park, I would prefer to ride the rollercoaster or other fast 
rides. 
(A) describes me very well 
(B) describes me somewhat 
 (C) does not describe me very well 
 (D) does not describe me at all 
 
9. I would like to travel to places that are strange and far away.   
(A) describes me very well 
(B) describes me somewhat 
 (C) does not describe me very well 
 (D) does not describe me at all 
 
10. I would never like to gamble with money, even if I could afford it. 
(A) describes me very well 
(B) describes me somewhat 
 (C) does not describe me very well 
 (D) does not describe me at all 
 
11. I would have enjoyed being one of the first explorers of an unknown land. 
(A) describes me very well 
(B) describes me somewhat 
 (C) does not describe me very well 
 (D) does not describe me at all 
 
12. I like a movie where there are a lot of explosions and car chases. 
(A) describes me very well 
(B) describes me somewhat 
 (C) does not describe me very well 
 (D) does not describe me at all 
 
13. I don’t like extremely hot and spicy foods. 
(A) describes me very well 
(B) describes me somewhat 
 (C) does not describe me very well 
 (D) does not describe me at all 
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14. In general, I work better when I’m under pressure. 
(A) describes me very well 
(B) describes me somewhat 
 (C) does not describe me very well 
 (D) does not describe me at all 
 
15. I often like to have the TV or radio on while I’m doing something else, such as reading or 
cleaning up. 
(A) describes me very well 
(B) describes me somewhat 
 (C) does not describe me very well 
 (D) does not describe me at all 
 
16. It would be interesting to see a car accident happen. 
(A) describes me very well 
(B) describes me somewhat 
 (C) does not describe me very well 
 (D) does not describe me at all 
 
17. I think it’s best to order something familiar when eating in a restaurant. 
(A) describes me very well 
(B) describes me somewhat 
 (C) does not describe me very well 
 (D) does not describe me at all 
 
18. I like the feeling of standing next to the edge on a high place and looking down. 
(A) describes me very well 
(B) describes me somewhat 
 (C) does not describe me very well 
 (D) does not describe me at all 
 
19. If it were possible to visit another planet or the moon for free, I would be among the first in 
line to sign up. 
(A) describes me very well 
(B) describes me somewhat 
 (C) does not describe me very well 
 (D) does not describe me at all 
 
20. I can see how it must be exciting to be in a battle during a war. 
(A) describes me very well 
(B) describes me somewhat 
 (C) does not describe me very well 
(D) does not describe me at all  
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